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ABSTRACT 
 
 
 
Toalston, Jamie E. Ph.D., Purdue University, August 2011. Peri-Adolescent Alcohol 
Consumption Enhances the Reinforcing and Stimulatory Properties of Ethanol Within the 
Adult Mesolimbic Dopamine System in Alcohol Preferring P Rats. Major Professor: 
James M. Murphy. 
 
 
 
 Research in the alcohol preferring (P) rat has indicated that peri-adolescent 
alcohol (EtOH) consumption enhances the acquisition of oral operant EtOH self-
administration, inhibits the extinction of responding for EtOH, augments EtOH-seeking 
behaviors, and increases relative reward value of EtOH during adulthood. Experiment 1 
was conducted to determine if these adult effects of peri-adolescent EtOH intake could 
be observed using an Intracranial Self-Administration (ICSA) model. It was hypothesized 
that an increased sensitivity to the rewarding actions of EtOH would be manifested in 
peri-adolescent-EtOH-exposed subjects compared to naive subjects when the 
opportunity to self-administer EtOH to the posterior ventral tegmental area (pVTA) is 
available in adulthood. The pVTA is a primary site for EtOH’s reinforcing and rewarding 
properties in the mesolimbic dopamine (DA) system. Experiment 2 was a dose-response 
examination of the effects of EtOH administered to the pVTA on downstream DA efflux 
in the nucleus accumbens shell (AcbSh) via a joint Microinjection-Microdialysis 
(MicroMicro) procedure. 
  Male P rats were given 24-h free-choice exposure to 15% volume/volume EtOH 
from postnatal day (PD) 30 to PD 60, or remained experimentally naive, with ad lib food 
 
x 
 
and water. By the end of the periadolescent exposure period, average consumption was 
7.3 g/kg/day of EtOH. After PD 75, periadolescent-EtOH-exposed and naïve rats were 
either implanted with an injector guide cannula aimed at the right pVTA for ICSA 
(Experiment 1), or two cannulae, one aimed at the right pVTA (injector) and one at the 
ipsilateral AcbSh (microdialysis) for MicroMicro (Experiment 2). Following one week of 
recovery from surgery, ICSA subjects were placed in standard two-lever (active and 
inactive) operant chambers. Test sessions were 60 min in duration and occurred every 
other day for a total of 7 sessions. Rats were randomly assigned to one of 5 groups 
(n=4-9/group) that self-infused (FR1 schedule) either aCSF (vehicle, 0 mg%), 50, 75, 
100, or 150 mg% EtOH during 4 sessions, aCSF only for sessions 5 and 6 (extinction), 
and the initial concentration again for session 7 (reinstatement). MicroMicro subjects 
received six days of recovery from surgery, probe implantation the day before testing, 
and then continuous microdialysis for DA with 15 min microdialysis samples collected 
before, during, and then two hrs after 10-min pulse microinjection of either aCSF 
(vehicle, 0 mg%), 50, 75, 100, or 150 mg% EtOH. 
  Neither EtOH-exposed nor naive groups of P rats self-infused the aCSF or 50 
mg% EtOH concentration. While the naive group did not self-infuse the 75 or 100 mg% 
EtOH concentrations, the peri-adolescent EtOH-exposed group of P rats did readily 
discriminate the active lever from the inactive lever at these concentrations. Both groups 
self-infused the 150 mg% EtOH concentration. Pulse microinjections of EtOH during the 
MicroMicro procedure revealed that 75 and 100 mg% concentrations of EtOH increased 
downstream DA in the AcbSh of EtOH-exposed, but not naïve, subjects. 150 mg% EtOH 
increased downstream DA in both adolescent treatment groups. 
  Overall, the results indicate that consumption of EtOH by P rats during peri-
adolescence increases the reinforcing properties of EtOH in the pVTA in adulthood. The 
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results also indicate that there were differential effects of peri-adolescent EtOH exposure 
on DA efflux in the AcbSh. This provides evidence that peri-adolescent EtOH-exposure 
produces long-lasting alterations in neural circuitry involved in EtOH-reinforcement, 
during adulthood. 
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1. BACKGROUND 
 
 
 
Alcohol and Adolescence: A Period of Vulnerability 
 
Within the United States alcohol use by anyone under the age of 21 is illegal. 
Nonetheless, surveys have found that over 70 percent of high school seniors have 
consumed alcohol and 30 percent have reported binge drinking, which is defined as 
consumption of five or more drinks at a time (Johnston et al., 2007). Lifetime prevalence 
of diagnosed alcohol abuse or dependence disorders in the United States is between 5 
and 13% of the population (Kessler et al., 2005). Worldwide, an estimated 76.3 million 
people have alcohol use disorders (Assanangkornchai and Srisurapanont, 2007). Given 
this large population of patients afflicted with continued maladaptive alcohol 
consumption, researchers have attempted to discover how, why, and particularly when 
alcohol consumption progresses from casual intake to a neuropsychological disorder. 
What has been labeled as a "downward spiral" to EtOH addiction has several 
described phases (Koob and Le Moal, 1997). These include EtOH intake to the point of 
intoxication and pharmacologically rewarding effects, and at least one of the following: 
escalation of EtOH intake due to an increase in motivation to achieve greater reward, an 
increased clearance of EtOH from system (metabolic tolerance to its effects), requiring 
greater intake to create same rewarding effect, and systemic homeostatic adjustment 
requiring further EtOH to stave off withdrawal. This also involves changes that occur 
during withdrawal and/or long term EtOH abstinence. Forward and backward feedback 
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loops intertwine these effects in many ways, and are observable at several levels, 
behaviorally and cellularly. 
It has been observed that drinking experience early in life is positively correlated 
with alcohol abuse in adulthood (Kandel et al., 1992, Clark et al., 1998). Long-term 
epidemiological studies have found that those who drink before the age of 14 have a 
four times greater chance of developing a dependence on alcohol during their lifetime, 
compared to those who do not drink until after age 20 (Grant and Dawson, 1997). Fifty 
percent of the alcoholic population first manifests DSM-IV-diagnosable alcoholism by 19 
years of age (Moss et al., 2007), indicating that the biological basis for alcoholism has 
already completely manifested before legal adulthood (and presumed cognitive maturity) 
has even arrived. This suggests that adolescence may be a time when neural systems 
are particularly vulnerable to drugs of abuse, like alcohol. The full effects of alcohol 
administration during adolescence are not yet understood, although it is agreed that 
adolescent alcohol consumption disrupts proper scaffolding of some brain structures that 
develop during this time period, including the cerebral cortex and limbic system (Crews 
et al., 2007).  
Binge drinking at these early ages has become a particular area of concern. 
Higher levels of EtOH in the blood putatively mean greater effects on neurochemistry. 
Greater effects on neurochemistry are likely to lead to long-lasting adaptive changes that 
disrupt normal functioning. Studies of human twins has found that excessive alcohol 
consumption in adolescence predicts later alcohol use problems better than lower levels 
of alcohol consumption (Poelen et al., 2009). Unfortunately, on average, underage 
alcohol drinkers have been found to consume more alcohol per bout than those 
surveyed over the age of 21 (4.9 vs. 2.8 drinks) (Substance Abuse and Mental Health 
Services Administration Office of Applied Studies, 2008).  
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 Adolescence is a time of complexity. Puberty, or sexual maturity, is the hallmark 
of adolescence. Developmental transitions, including physical, social, and cognitive 
maturational factors, together contribute towards producing a time period sensitive to 
production of drug abuse (Spear, 2000). Hormones, adrenal and gonadal in nature, act 
on many systems of the body to change the composition and physical conformation of 
skeleton, body fat and muscle. Social and behavioral markers of adolescence include 
changes in stress, anxiety, and sensation-seeking thresholds. On a neural level, 
significant amounts of cortical and hippocampal synaptic pruning continues during late 
adolescence and early adulthood. Neurotransmitter receptors, including DA, 5-HT, and 
GABA, are reorganized systematically (Spear, 2000).  
Temporally, human adolescence is generally considered to encompass much of 
the teenage years, covering a time period before, during, and after puberty 
(menarche/spermarche), while also encompassing the aforementioned intellectual and 
psychosocial maturational processes. Regarding maturation in the United States, a 
human is legally a minor under parental control until the age of 18. Biologically, the 
process of sexual maturation of human females as a result of hypothalamic-pituitary-
gonadal (HPG) stimulation may start from as early as age 10 and continue for about 4 
years, while maturation of males begins around age 12 and continues for about 6 years 
(Windle et al., 2008). Metabolic fuel availability appears to have an influence on the 
onset timing of these processes, linking childhood obesity to earlier onset of puberty 
(Ebling, 2005). 
The modeling of adolescent EtOH consumption in animals is one strategy to 
elucidate a more precise understanding of the effects EtOH has on the developing brain. 
Skeletal maturation and body weight also have an influence on onset of sexual viability 
in rodents. Vaginal opening in the female rat occurs at about 100 grams of weight, 
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between days 33 and 42, and estrous begins approximately one week later. Sexual 
maturity occurs at body length of 148 to 150 mm in male rats. Testes descend to the 
scrotum at about day 15 of age, and sperm are produced around day 45, yet optimal 
production is not achieved until 75 days (Suckow et al., 2006). Adolescence in the rat 
has been described to begin as early as postnatal day 20 in the female, while most 
obvious signs of puberty in the male rat have occurred as late as day 55 (Odell, 1990, 
Spear, 2000). It is for these reasons that in the alcohol field, many studies use an 
approximate window from postnatal day 30 to 60 to encapsulate a time period for both 
male and female subjects that may be described as peri-adolescence (Spear, 2000, Bell 
et al., 2006). This captures maturational changes during and after sexual maturity in an 
attempt to mirror human adolescence, which extends to physical and psychosocial 
changes beyond mere menarche/spermarche. 
 
Observation of Adolescent EtOH Intake 
 
Changes following EtOH intake during adolescence have the potential to affect 
social interest, novelty-seeking behaviors, attentional properties, and emotional state. 
Given what is known about hormone changes during this time period (testosterone, 
estrogen, growth hormones, anxiety-related hormones), and brain changes due to 
hormone changes, a number of interactions may occur. Epidemiological evidence 
indicates that drug-taking behavior ultimately affects many of these changes increasing 
subsequent drug-seeking behavior and drug-reward incentive value.  
As described with humans (Substance Abuse and Mental Health Services 
Administration Office of Applied Studies, 2008, Poelen et al., 2009), adolescent rats 
have been found to voluntarily consume more EtOH by body weight than adult rats given 
the same amount of access, in both free-choice and limited access experiments (Bell et 
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al., 2003, 2004, 2006, Doremus et al., 2005, Vetter et al., 2007, Vetter-O'Hagen et al., 
2009). Adolescents are innately different from adults in regards to sensitivity to the 
hypnotic, anxiolytic, and motor-impairing effects of EtOH. The decreased sensitivity to 
these aversive effects of EtOH may fail to discourage further drinking in adolescence 
(Brunell and Spear, 2006). In addition, impulsive behavior in human adolescence has 
been found to predict heavy drinking in adulthood (Verdejo-Garcia et al., 2008), while 
heavy drinking in early adolescence has been shown to predict an increase in impulsive 
behavior in later adolescence (White et al., 2011). 
EtOH consumption by the adolescent rat has been shown to have a significant 
impact on adult EtOH drinking behavior. For example, when juvenile (PD 22-28) and 
adult rats are given given similar access to EtOH, the juvenile-exposed rats show a 
greater willingness to drink 30% EtOH in adulthood (Truxell et al., 2007). In the alcohol 
preferring (P) rat, peri-adolescent EtOH consumption enhances EtOH intake during 
adulthood when the rats are tested under both free-choice and operant conditions 
(McKinzie et al., 1998b). Subjects given free-choice access to EtOH during adolescence 
acquire operant responding for EtOH faster than naïve subjects as well as those given 
the same amount of pre-exposure during adulthood (Rodd-Henricks et al., 2002a, b). 
These authors also reported differences that included increased time to extinguish 
responding when EtOH was no longer available in the operant setting, as well as 
enhanced relapse-like behaviors when EtOH availability was returned. 
The alcohol deprivation effect (ADE), as modeled by relatively long-term EtOH 
abstinence followed by a return to EtOH access, simulates precipitated relapse in the 
human condition, and has been observed in multiple laboratory species (Sinclair, 1971, 
Kornet et al., 1990, Spanagel et al., 1996, Agabio et al., 2000, Le and Shaham, 2002). 
Overt withdrawal symptoms after prolonged EtOH exposure last no longer than 1 week 
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in the rat (Cicero et al., 1971), but the ADE deprivation/abstinence interval encompasses 
periods beyond one week. The ADE is observed with manifestation of a spontaneous 
increase in EtOH intake, over previously normal drinking behavior, once access is 
restored (Sinclair and Senter, 1968). Some studies have revealed the absence of an 
ADE between adult- and adolescent-exposed subjects, given the above conditions 
(Tambour et al., 2008), but this may be a function of decreased procedural sensitivity. 
The P rat shows an increased ADE response following adolescent access, compared to 
adult subjects receiving the same exposure/abstinence periods (Rodd-Henricks et al., 
2002a, b). In Wistar rats, acamprosate injections reduce the expression of an ADE 
enhancement in adult-exposed subjects, but not in adolescent-exposed subjects, 
suggesting that adolescent-initiated EtOH drinkers incur some adaptive resistance to the 
neurochemical actions of acamprosate treatment (Fullgrabe et al., 2007). 
All of these studies combined illustrate that EtOH consumption by the adolescent 
rat has significant impact on adult EtOH drinking behavior, above and beyond any effect 
of mere prior access (i.e., differences seen relative to adult exposure). 
 
Adolescent EtOH in Selectively Bred Rats 
 
 Forced-access experimental designs are often necessary to examine effects of 
high levels of EtOH. Free-choice access, where the subject determines how much EtOH 
is administered, can shed light on changes in motivation to seek EtOH and related 
differences in adult neural makeup. For example, following free-choice access to EtOH 
during adolescence, Wistar rats show more pronounced adult stress-induced EtOH 
consumption, compared to those exposed to EtOH in adulthood (Fullgrabe et al., 2007). 
However, to observe the long-term effects of EtOH following high amounts of adolescent 
EtOH consumption it is very useful to employ subjects selectively bred for high EtOH 
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intake and/or preference. These subjects readily consume EtOH voluntarily and attain 
pharmacologically relevant elevation of blood ethanol concentrations. 
Selective breeding for high EtOH consumption in laboratory subjects is meant to 
model humans with a positive family history of alcoholism, as there is evidence of a 
human genetic predisposition for high risk alcohol use. Rodents selectively bred for high 
EtOH consumption include the P rat, high alcohol drinking (HAD) replicate rat lines, 
Sardinian preferring (sP) rats, ALKO alcohol accepting (AA) rats, and high alcohol 
preferring (HAP) mice. Cicero (1980) created a set of criteria for producing a valid animal 
model of alcoholism. These include 1) subjects should orally self-administer EtOH, 2) the 
amount of EtOH consumed should relate to pharmacologically relevant blood alcohol 
levels (BAL), 3) subjects should consume EtOH for pharmacological effect, not just taste 
or caloric load, 4) subjects should find EtOH consumption positively reinforcing, 5) 
chronic EtOH should lead to metabolic/functional tolerance, and 6) chronic EtOH should 
lead to dependence/observable withdrawal. This list was expanded by McBride and Li to 
include evidence of relapse-enhanced drinking behavior (1998). The previously-
mentioned P rat, which was selectively bred for preference of 2 to 1 for 10% v/v EtOH 
over water and at least 5 g/kg/day self-administered EtOH (Lumeng et al., 1977), is 
believed to meet these criteria (McBride and Li, 1998, Murphy et al., 2002, Bell et al., 
2005, 2006). The P rat is the animal model used in this study.  
In the P rat, peri-adolescent consumption has been demonstrated to enhance 
EtOH intake in adulthood in both free-choice and operant settings (McKinzie et al., 
1998b., Rodd-Henricks et al., 2002a, b, McBride et al., 2005). Following peri-adolescent 
access to EtOH in the P rat, increased clearance of DA has been seen in the nucleus 
accumbens (Acb) as measured by no-net-flux microdialysis for DA (Sahr et al., 2004), 
where several concentrations of DA are perfused, then analyzed for DA change. 
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Adolescent EtOH exposure also increases breakpoint responding for operant oral EtOH 
access, indicating a change in the reward salience of EtOH (Toalston et al., In 
Preparation). Peri-adolescent EtOH consumption by the P rat therefore appears to 
cause significant impact on adult EtOH drinking behavior. 
 
Change in Reward Value of EtOH Following Exposure 
 
Operant techniques can examine alterations in the amount of work a subject will 
perform to obtain reinforcement, and are often used to examine subjective changes in 
the reinforcing properties of EtOH (Hodos, 1961, Ciccocioppo et al., 2001, Rodd et al., 
2004a). It has previously been observed that while P rats will consume large volumes of 
sweetened liquids, they will still concurrently consume pharmacologically relevant 
volumes of EtOH (Lankford et al., 1991). But given access to sweetened liquids alone, P 
rats will work to consume sweetened liquids at high volume, higher even than that 
observed for EtOH (Nowak et al., 1999, Czachowski and Samson, 2006). This was also 
observed in our laboratory’s previous study (Toalston et al., In Preparation), where peri-
adolescent P rats that had free-choice access to SACC responded more as adults for 
SACC alone than for EtOH alone. When the operant breakpoint was tested, however, 
subjects with free-choice peri-adolescent access to EtOH were willing to work to a higher 
level for EtOH than subjects with free-choice peri-adolescent access to SACC were 
willing to work for SACC. This supports the idea that, in the P rat, EtOH is a salient 
reinforcer and that peri-adolescent access to EtOH has a greater effect on adult 
behavior than that observed following peri-adolescent SACC (Toalston et al., In 
Preparation). Repeated accesses and abstinences from EtOH also increases the oral 
operant breakpoint for EtOH in both P and HAD rats (Rodd et al., 2003, Oster et al., 
2006).  
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Behavioral Changes Following EtOH Exposure 
 
Various studies have observed long-lasting behavioral effects in adult animals 
following adolescent EtOH treatments, which point to possible detrimental cognitive 
consequences. EtOH administration impairs performance on a number of tasks in 
adolescence to a greater degree than observed in adult-exposed subjects. Chronic 
injections of EtOH during adolescence increase novelty-seeking behavior in adulthood 
compared to naïve subjects (Stansfield and Kirstein, 2007). Repeated EtOH injections 
impair performance of adolescent subjects to a greater degree on a Morris water maze 
task than subjects tested during adulthood (Sircar and Sircar, 2005). Intermittent vapor-
chamber exposure to EtOH during adolescence affects spatial working memory in 
adulthood, as measured by performance on a Morris water maze task (Schulteis et al., 
2008). Adolescent EtOH-vapor exposed subjects display enhanced prepulse inhibition 
response, suggesting a form of behavioral inflexibility has been induced (Slawecki and 
Ehlers, 2005). This form of EtOH inhalation administration results in constant high levels 
of EtOH in the blood stream (Gilpin et al., 2008).  
Repeated administration of EtOH by injection during adolescence has resulted in 
adult subjects less sensitive to EtOH-induced loss of righting reflex, indicating long-term 
tolerance to some of the effects of EtOH, or alterations in the ontogeny of this effect 
(Matthews et al., 2008). Adolescent EtOH exposure has effects on sleep patterns that 
last long into adulthood (Ehlers and Criado, 2010), and responses to EtOH challenge in 
adolescence shows increased sensitivity to some EtOH effects (LMA, anxiolytic, ataxic) 
and decreased sensitivity to others (sedative/hypnotic) compared to adults (Hefner and 
Holms, 2007). These studies illustrate that EtOH treatment has measurable, specific 
effects on behavior and memory in adolescent laboratory subjects, both concurrent to 
EtOH administration as well as without EtOH on board later, in adulthood. 
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Mesolimbic Dopamine System and Effects of EtOH  
 
Systemic EtOH application (like that seen via oral EtOH consumption) increases 
EtOH concentrations in the blood, which has the effect of in vivo bathing of all body cells 
and their communications systems in EtOH until it is metabolized and removed from the 
blood stream. Even acute, one-time EtOH administration has deleterious effects on the 
normal functioning of neural substrates involved with reward (Crews et al., 2006). 
Regarding these neural substrates, DA and related serotonin (5-HT) pathways have 
been repeatedly implicated in high EtOH consumption in rodent models (Murphy et al., 
1985, McBride et al., 1991, Di Chiara, 1997).  
Tsai's ventral tegmental area, the A10 seat of DA neurons cell bodies, is a 
heterogeneous structure, with five main nuclei (Tsai, 1925, Oades and Halliday, 1987). 
The VTA is strongly implicated in cognitive and behavioral processes including 
motivation and reward, as well as disorders arising from malfunction of these processes; 
e.g., addiction and schizophrenia (Laviolette, 2007, Murray et al., 2008). VTA 
dopaminergic projections run primarily to mesocortical and mesolimbic areas, but also 
mesostriatal, mesodiencephalic, and mesorhombencephalic areas (Ikemoto, 2007).  
Mesolimbic VTA DA reward circuitry has been narrowed down further, into meso-
ventromedial and meso-ventrolateral striatal systems (Ikemoto, 2007). The former 
projects from the posterior areas of the VTA to the AcbSh and has been implicated in 
processing rewarding stimuli, while the latter projects from the anterior/lateral areas of 
the VTA to the nucleus accumbens core (AcbC) and has been implicated in processing 
noxious stimuli (Faure et al., 2008, Brischoux et al., 2009). The rodent VTA has 
therefore commonly been separated into anterior (aVTA) and posterior (pVTA) 
dimensions, with this separation occurring at approximately 5.2/5.3 posterior to bregma 
as seen on the Paxinos and Watson rat atlas (1986). More generally speaking, posterior 
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VTA DA projections largely aim to the PFC and AcbSh, while anterior VTA DA cells 
project predominately to AcbSh and AcbC (Brog et al., 1993). A second main set of 
neurotransmitter-producing cell bodies within the VTA is GABAergic, which can 
interconnect with each other via gap junctions. Furthermore, terminating in the VTA are 
serotonergic, acetylcholinergic, GABAergic, and opioid projections (Ikemoto, 2007). 
The mechanisms of action of rewarding drugs (including EtOH) involving the VTA 
is varied, but it has been observed that all drugs that are rewarding to humans are 
associated with DA release in the Acb, while drugs that are noxious decrease DA in this 
area (Di Chiara and Imperato, 1988). Thus, the reciprocal interaction that the VTA has 
with the Acb is a field of intense study. 
Enhancement of neural activity in connection with EtOH within the VTA has been 
observed. In vitro, acutely administered EtOH increases the firing rate of DA neurons in 
the VTA (Brodie et al., 1999). VTA DA neurons of mice with higher sensitivity to EtOH, 
as evidenced by place preference conditioning (CPP) response, but lower propensity to 
consume EtOH, show stronger response to EtOH application than those with lower place 
preference conditioning and higher EtOH drinking behavior (Brodie and Appel, 2000). It 
has also been observed that chronic EtOH treatment increases the excitation of VTA DA 
neurons (Brodie, 2002).  
Part of the effects EtOH has on DA in the VTA has been attributed to mediation 
by the serotonin system (Murphy et al., 1992). Serotonin neurons in the dorsal and 
median raphe nuclei terminate in both the VTA and Acb. 5-HT3 receptor antagonism 
reduces the stimulation of DA release by EtOH in the Acb (Carboni et al., 1989), 
suppresses EtOH-stimulated release of DA in the VTA (Campbell and McBride, 1995), 
and suppresses acquisition and maintenance of responding for ICSA of EtOH in the VTA 
(Rodd-Henricks et al., 2003). Increasing 5-HT enhances the excitability of DA neurons in 
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the VTA (Buck et al., 2004), however 5-HT3 antagonism does not suppress ICSA for the 
EtOH metabolite acetaldehyde (Rodd et al., 2005c).  
Downstream from the VTA in the mesolimbic pathway, the Acb also shows 
evidence of enhancement of neural activity as a result of EtOH treatment or drinking. 
Systemically applied EtOH has been shown to increase DA release in the Acb (Di Chiara 
and Imperato, 1985). Chronic and intermittent EtOH exposure increases D2 receptor 
binding density in the AcbSh (Sari et al., 2006), showing specific evidence of 
compensatory changes in this area. Interestingly, however, self-administration of EtOH 
has also been observed to decrease DA response in the Acb following EtOH challenge, 
compared to yoked forced access subjects that do not show this effect (Nurmi et al., 
1996). Overall, these findings are consistent with a strong link of the Acb to EtOH-
seeking behavior; however, the relationship may be more complex than a simple 
unidimensional EtOH administration effect. 
Enhanced EtOH intake in rodent subjects is related to lower endogenous basal 
5-HT in regions of the mesocorticolimbic neural circuit (Murphy et al., 1987), as well as 
fewer 5-HT neurons in these areas (Zhou et al., 1994). EtOH challenge produces an 
increase in accumbal monoamine metabolites DOPAC, HVA, and 5-HIAA (Murphy et al., 
1988), which suggests activation of these systems. However, in chronically exposed 
subjects this response is muted compared to naïve subjects (Murphy et al., 1988). 
Moreover, serotonin microinfused into the VTA increases DA efflux in the Acb (Guan and 
McBride, 1989). 
The VTA projects GABA-releasing neurons to the Acb, with these VTA neurons 
receiving connections from the PFC (Carr and Sesack, 2000). GABA(A) antagonists 
cause a release of DA into the Acb when administered to the aVTA (Ikemoto et al.,  
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1997b). DA neurons of the VTA and medium spiny neurons of the Acb display evidence 
of increased excitability in synaptic areas, indicating a role from glutamate (Stuber et al., 
2010). 
Opioids are also a factor within the reinforcement neurocircuit (Di Chiara et al., 
1996). A delta-opioid antagonist co-perfused into the Acb with EtOH prevented EtOH-
induced DA increases, but not when co-perfused with cocaine, suggesting a role for 
delta-opioid receptors in the Acb specific to EtOH (Acquas et al., 1993). Genetic 
analyses of human families have shown that high risk for alcoholism is associated with 
carrying a variation in gene OPRK1, which reduces transcription activity of the kappa-
opioid receptor (Edenberg et al., 2008). 
 Taken together, these findings illustrate how the effects of EtOH on the VTA-Acb 
system are obviously varied and complex, even without the added factor of adolescent 
development. As indicated above, animals genetically predisposed to excessive EtOH 
drinking or EtOH-seeking behavior (e.g., P Rats) are known to have endogenous 
alterations in neurochemical pathways compared with their alcohol-non-preferring (NP) 
or outbred (Wistar) counterparts. These neurochemical differences likely mediate some 
responses to EtOH. Thus the effects of adolescent EtOH on these pathways could 
further enhance neuroadaptations to enhance the already predisposed state for EtOH-
seeking in the adult animal. 
 
Neural Stunting Following EtOH Exposure 
 
Binge EtOH results in greater brain damage in young adolescent rats compared 
to adult rats (Crews et al., 2000). EtOH exposure in adolescence dose-dependently 
stunts normal cell proliferation in the forebrain and dentate gyrus, with this effect 
occurring after a single peripheral injection of EtOH (Crews et al., 2006). In the 
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hippocampus, EtOH exposure during adolescence alters the track and survival of 
progenitor cells, possibly by reducing time in critical stages of the cell cycle (McClain et 
al., 2011a), as well as creating marked activation of select microglia, suggesting 
induction of immune-like responses (McClain et al., 2011b). These few recent studies 
show how on a level of cellular development, EtOH application during adolescence 
disrupts normal scaffolding of brain material, and that EtOH administration during this 
critical period of development can have long term harmful effects on neural functioning. 
 
Changes in Neurotransmission Following EtOH Exposure 
 
Adolescent subjects exhibit higher basal DA levels, as well as levels of D1 and 
D2 receptors, than adult subjects, emphasizing that DA tone differs overall in 
adolescents (Pascual et al., 2009). Elevated DA levels have been suggested by 
Melendez et al. to mediate ethanol-seeking behavior (2002) indicating that elevated 
basal DA may render ethanol-exposed adolescent rats more vulnerable to developing 
adult-onset ethanol-seeking behaviors than naïve subjects. 
Repeated injections of EtOH during adolescence increases basal DA in the Acb 
during adulthood (Badanich et al., 2007). Repeated EtOH exposure in adolescence 
elevates accumbal DA levels of the adolescent Acb septi (Philpot and Kirstein, 1998). 
Similarly, this treatment elevates adult Acb DA levels, and decreases the DA response 
to an EtOH challenge within this brain structure (Philpot et al., 2009). Also, it has been 
suggested that repeated adolescent EtOH exposure decreases the time required to see 
the DA increase induced by EtOH administration into the Acb during adolescence 
(Philpot and Kirstein, 2004). Repeated injections of EtOH affects the accumbal ratio of 
DA to a primary metabolite, 3,4-dihydroxyphenylacetic acid (DOPAC), at several time 
points during adolescence (Philpot and Kirstein, 2004). This is in agreement with the 
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finding that free-choice adolescent EtOH exposure by P rats PD 30-60 results in greater 
DA clearance during no-net-flux microdialysis in the Acb, suggesting a general increase 
in DA release has occurred (Sahr et al., 2004). The authors also reported more 
protracted DA response to an EtOH challenge injection, compared to naïve rats. 
Repeated EtOH treatment decreases the amount of DRD2 in the Acb of adolescent but 
not adult subjects (Pascual et al., 2009)  
Repeated injections of EtOH during adolescence results in subjects that have an 
increase in extracellular Acb glutamate in response to an EtOH challenge injection, as 
opposed to similarly-treated adult subjects which showed a decrease in extracellular 
glutamate (Carrarra-Nascimento et al., 2011) likely related to input from the PFC, a 
connection that may influence EtOH reward (Kalivas and Volkow, 2005). Low doses of 
naltrexone injections were more effective at slowing acquisition of EtOH drinking 
behavior in adolescent P rats compared to adult subjects, with less tolerance observed 
in the adolescent animals as well (Sable et al., 2006). This suggests that EtOH 
experience has a differential effect on adult and adolescent subjects, and that this can 
translate to an increase, or decrease, in the efficacy of traditional treatment options. 
 
Interaction of Adolescence, Anxiety/Stress, and EtOH 
 
Behavioral reaction to stress has been related to the development of alcoholism. 
In particular, EtOH abuse has been connected with dysfunction within the hypothalamic-
pituitary-adrenal (HPA) axis, a large portion of neural system in place that processes 
physical and psychological stress (Koob, 2010). It is unknown whether ultimately this 
neuroendocrine disruption is causal in EtOH abuse, or vice versa, but evidence shows 
that EtOH dependence does indeed affect HPA functioning (Richardson et al., 2008). 
Furthermore, an abnormal stress response has been correlated with children of 
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alcoholics, who are identified as family history positive for alcoholism (Peterson and Pihl, 
1990). Higher environmental stress exposure in both adolescent children of alcoholics 
and control subjects increased risk for developing substance use disorders (King and 
Chassin, 2008). Stress has been linked with higher relapse rates, making responses to 
stress a factor in the continuation of EtOH drinking (Sinha et al., 2011). 
 Within the HPA loop, corticotropin releasing factor (CRF) in the paraventricular 
nucleus (PVN) of the hypothalamus is strongly involved in stress response, and has 
been connected to hypotheses about creation of addictive states (Koob, 2010). For 
example, repeated stress has been shown to affect the VTA and Acb in ways similar to 
some drugs of abuse (Ortiz et al., 1996). Also within the HPA loop, increases in 
corticosteroid hormones have been shown to increase DA release in the Acb (Imperato 
et al., 1989). Adrenalectomy results in decreased basal DA in the AcbSh, as well as 
reduced DA reactivity during drug administration or stress (Barrot et al., 2000). Chronic 
corticosteroid administration results in decreased DA synthesis and DA turnover in the 
Acb (Pacak et al., 2002). Therefore, acute corticosteroid increases in turn result in 
increased basal DA, while chronic corticosteroid increases result in decreased basal DA 
in this area, resulting in sensitization that can enhance drug effects (Marinelli and 
Piazza, 2002). 
Following repeated administration and withdrawals from EtOH, adolescents 
sensitized to decreased social interaction (anxiety-like behavior) longer than adult 
subjects given the same treatment (Wills et al., 2009), an effect that also requires higher 
doses of CRF to diminish (Wills et al., 2010). Combined with higher basal levels of CRF 
in the PVN and central nucleus of the amygdala, this has been interpreted as lower 
sensitivity to CRF compared to adults (Wills et al., 2010). Adolescents are less affected 
by the anxiogenic effects caused by both acute and chronic EtOH withdrawal, as 
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compared to adults, even when controlling for EtOH clearance concentrations (Doremus 
et al., 2003). This shows a form of insensitivity to EtOH effects (Spear, 2000). 
Studies of macaque monkeys have shown that adolescent exposure to EtOH 
increases later drinking behavior compared to equivalent adult exposure in stressed 
peer-reared subjects compared to unstressed subjects, suggesting that stress has 
affected biological risk for high EtOH consumption (Barr et al., 2004). While chronic 
stress decreases adolescent EtOH intake, subjects still consume more EtOH g/kg than 
adults receiving the same treatment (Brunell and Spear, 2005). Male Wistar rats 
consuming EtOH during adolescence later increased EtOH consumption following stress 
to a greater degree than adult-exposed subjects (Siegmund et al., 2005). Following free-
choice access to EtOH during adolescence, subjects show more pronounced adult 
stress-induced EtOH consumption, compared to those exposed in adulthood (Fullgrabe 
et al., 2007), and peri-adolescent EtOH vapor exposure affects later CRF responses in 
the PVN to an EtOH challenge, indicating that these subjects show a blunted response 
to this stressor (Allen et al., 2011b). P rats exposed to EtOH in adolescence show 
evidence of reduced novelty-induced anxiety compared to naïve subjects (Salimov et al., 
1996).  
As the stress-response system continues to develop during adolescence, there is 
therefore possibility for disruption of its natural course by EtOH administration at this 
time. This disruption may translate to differential response to EtOH, stress, and the 
interaction between the two, in adulthood. 
 
Study Rationale and Hypotheses 
 
Adolescent operant breakpoint studies (Rodd et al., 2003, Oster et al., 2006, 
Toalston et al., In Preparation), combined with ICSA (Rodd et al., 2000) and adolescent 
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work (Bell et al., 2003), have particular relevance in the development of the present 
study. As free-choice EtOH access during adolescence can be argued to have altered 
reward saliency of EtOH in our previous studies, interest in other parameters for 
examining the mesolimbic reward pathways after peri-adolescent EtOH drinking was 
peaked. 
Past research has suggested that peri-adolescent EtOH consumption increases 
the subjective reinforcing properties of EtOH. The goal of this dissertation was to further 
examine the change in reinforcing properties of EtOH within the mesolimbic dopamine 
system induced by free-choice peri-adolescent EtOH consumption. Also, the intent was 
to examine whether peri-adolescent EtOH consumption enhances the stimulatory effect 
of EtOH on the mesolimbic dopamine system.  
In the present study, two experiments evaluate the effects of free-choice EtOH 
intake by P rats during peri-adolescence on later adult EtOH-reward seeking behavior. 
Two questions were addressed: (1) Does EtOH experience during peri-adolescence 
affect responding for ICSA of EtOH into the pVTA in adulthood? (2) Does EtOH 
experience during peri-adolescence increase release of DA in the AcbSh of adult P rats 
following pulsed microinjection of EtOH into the VTA? Together, these studies will 
improve our knowledge of the effects of peri-adolescent EtOH exposure on the 
mesolimbic DA reward pathway. And, by extension, this knowledge will facilitate the 
development of treatments targeting alcohol abuse and dependence. 
The overall hypothesis is that peri-adolescent self-administered EtOH results in 
long-term neuroadaptations within the mesolimbic DA system (VTA and AcbSh), 
increasing the reinforcing properties of EtOH in adulthood compared to EtOH-naïve 
subjects. 
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Experiment 1: ICSA 
 
Experiment 1 will address whether EtOH experience in peri-adolescence affects 
later responding for EtOH ICSA into the pVTA. The ICSA method can determine whether 
a specific brain region is involved in drug reward, by measuring operant bar-press 
behavior that results in administration of drug discretely into the respective region. 
Comparison of number of responses between different concentrations of EtOH creates a 
dose-response curve for a particular set of treatment conditions. In this case, we chose 
to examine the pVTA, a nucleus of dopaminergic neurons previously shown to support 
intracranial EtOH self-administration (Gatto et al., 1994, Rodd-Henricks et al., 2000). 
The research objective of the first experiment was to examine the extent to which 
EtOH consumption during peri-adolescence by P rats altered the neurocircuitry involved 
in the reinforcing properties of EtOH. The first working hypothesis was that EtOH-
exposure-induced neuroadaptations during peri-adolescence result in an adult neuronal 
system projecting from the pVTA that is more sensitive to the reinforcing properties of 
EtOH compared to EtOH-naïve subjects. This increase in responsiveness to the 
stimulating effects of EtOH on pVTA DA neurons would be reflected by a shift of the 
dose-response curve to the left compared to EtOH-naive subjects. ICSA therefore will 
determine whether the dose-response curve for EtOH in adulthood differed between 
adolescent-EtOH-exposed and naïve subjects. The null hypothesis in this situation, 
where this neurocircuitry has no change in sensitivity following EtOH exposure in peri-
adolescence, would be supported by no difference in responsiveness across EtOH 
concentrations to the stimulating effects of EtOH on pVTA DA neurons. 
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ICSA Background 
 
Intracranial self-administration methods are useful for determining which discrete 
brain regions are involved in the initiation and maintenance of drug reinforcement 
(McBride et al., 1999). Comparison of the number of operant responses and infusions to 
the brain site between different concentrations of a drug creates a dose-response curve 
for a particular set of treatment conditions for a given microinfusion site in the brain. In 
this case, we chose to examine the pVTA, which is the seat of dopaminergic neuronal 
cell bodies that project axons to the AcbSh and other mesolimbic terminal sites. 
 The no-tangle form of microinjection of drug used in this experiment was 
pioneered by Criswell for use with chemotrodes (1977) to follow up previous chemical 
stimulation methods more difficult to administer (Myers, 1972). This was again refined by 
Bozarth and Wise (1980). In this procedure, a measured electric current passes between 
two electrodes submerged in a tank of infusate, producing hydrogen gas, and the 
increased pressure in the tank forces the desired small amount of infusate, which has 
been calibrated to the respective current, into the brain through a cannula attached to 
the tank. Monitored constant low current keeps infusate pressure stationary during inter-
injection intervals (Goeders and Smith, 1987). 
It is widely accepted that the VTA-Acb DA connection is involved in reward and 
reinforcement behavior (Wise and Rompre, 1989, Ikemoto and Panksepp, 1999). The 
pVTA has been shown to support EtOH self-administration, while the aVTA does not 
(Rodd-Henricks et al., 2000). Also self-administered in this area is acetaldehyde, a 
metabolite of EtOH (Rodd-Henricks et al., 2002c). D1/D2 agonists administered alone do 
not support ICSA in the AcbSh, while co-administration of the associated agonists does 
(Ikemoto et al., 1997a). Similar to EtOH, differences in opiate reward within the anterior 
and posterior VTA have also been observed (Carlezon et al., 2000). Regarding this, 
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GABA(A) antagonists are self-administered into the aVTA but not pVTA (Ikemoto et al., 
1997c). GABA(A) receptors in the pVTA but not aVTA have been found to be involved in 
binge consumption of EtOH (Melon and Boehm, 2011). While VTA DA neurons are 
excited by AMPA administration, increasing DA in the Acb (Kretschmer, 1999), AMPA 
itself is not self-administered into the VTA (Ikemoto et al., 2004).  
As described earlier, the research objective of the first experiment was to 
examine the extent to which EtOH consumption during peri-adolescence in P rats 
altered the development of neurocircuitry involved in the reinforcing properties of EtOH. 
The hypothesis was that EtOH-exposure-induced neuroadaptations result in an adult 
neurocircuitry system in the pVTA of adolescent-exposed animals that is more sensitive 
to the reinforcing properties of EtOH compared to EtOH-naive subjects. This increase in 
responsiveness to the stimulating effects of EtOH on pVTA DA neurons would be 
reflected by a shift of the dose-response curve to the left compared to EtOH-naive 
subjects. ICSA therefore determined whether the dose-response for EtOH in adulthood 
differed between adolescent-EtOH-exposed and -naïve subjects.  
However, ICSA only examines effects on neurocircuitry at one site. To elucidate 
"downstream" effects of ICSA of EtOH in the pVTA, the current studies will also perform 
a concurrent analysis of a second site as pVTA EtOH is being infused. Because a 
concurrent analysis in the Acb during actual ICSA is technically very difficult and the 
findings may be confounded by variables such as motor effects, one way to accomplish 
this goal is an experimenter-administered (via a calibrated current generator) series of 
pulsed microinjections mimicking a classic ICSA bout with concurrent microdialysis in 
the downstream site. For the purpose of this paper, the method name is shortened to 
MicroMicro. 
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Experiment 2: MicroMicro 
 
Experiment 2 will address whether EtOH experience during peri-adolescence 
enhances release of DA in the AcbSh of adults following EtOH administered into the 
VTA. This experiment used a microinjection-microdialysis methodology. This involves 
experimenter-administered EtOH directly into a cell body region (pVTA) at a 
concentration that has been shown to support self-administration in previous reports, 
coupled with a microdialysis probe implanted into a "downstream" DA cell terminal 
region (AcbSh), which provides a controlled examination of the EtOH effects on 
neurotransmitter release via the assay of the dialysate. 
Specifically, the research objective of the second experiment was to examine the 
effects of peri-adolescent EtOH drinking on adult DA release in the AcbSh after 
microinjection of relevant concentrations of EtOH in the pVTA. The second working 
hypothesis was that peri-adolescent neuroadaptations result in an adult neurocircuitry 
system (DA neurotransmission between the "upstream" pVTA and "downstream" AcbSh 
projection area) that has greater sensitivity to EtOH stimulation. This increase in 
responsiveness to the stimulating effects of EtOH on pVTA DA neurons was expected to 
be reflected by an increase in DA release in the AcbSh in response to lower 
concentrations of EtOH, essentially creating a shift to the left in the dose-response 
curve. Therefore, the microinjection-microdialysis techniques compared DA in vivo efflux 
between peri-adolescent EtOH-exposed and EtOH-naïve subjects in the AcbSh following 
EtOH administration into the pVTA. The null hypothesis in this situation would be 
indicated by no change in responsiveness to the stimulating effects of EtOH on pVTA 
DA neurons, as measured by no difference in DA response, and would suggest no 
differences between the neurocircuitry of subjects exposed to EtOH during peri-
adolescence compared with EtOH-naïve P rats. 
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MicroMicro Background 
 
This pulsed MicroMicro methodology can be used to closely examine changes in 
downstream neurotransmitter release in response to ICSA-like administration in real time 
(Ding et al., 2011). Unlike ICSA, this involves experimenter-administered EtOH directly 
into a cell body region, in a concentration that was demonstrated to be self-administered 
as described in previous reports (Gatto et al., 1994, Rodd et al., 2004c), coupled with a 
microdialysis probe implanted into a downstream DA cell terminal region. This approach 
provides a controlled examination of the EtOH effects on neurotransmitter release via 
HPLC assay of the dialysate. In this study, EtOH is applied into the pVTA, while 
microdialysis for extracellular DA levels is performed in the AcbSh. The pulsing of EtOH 
mimics the pattern of EtOH administration during a bout of ICSA responding, complete 
with mock time-out intervals. 
As described earlier, the research objective of the second experiment was to 
examine, in adulthood, the effects of peri-adolescent EtOH drinking on DA release in the 
AcbSh after microinjection of relevant amounts of EtOH into the pVTA. The hypothesis 
was that adolescent P rats exposed to EtOH would exhibit neuroadaptive changes in 
adult neurocircuitry (DA neurotransmission between the "upstream" pVTA and 
"downstream" AcbSh projection area) yielding an adult system that is more sensitive to 
EtOH reward, and reinforcement, compared to subjects not exposed to EtOH during 
peri-adolescence. This increase in responsiveness to the stimulating effects of EtOH on 
pVTA DA neurons was expected to be reflected by an increase in DA release in the 
AcbSh in response to lower doses of EtOH in the pVTA. This is presumed to mediate the 
behavioral outcome seen as a shift to the left in the dose-response curve for the ICSA of  
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EtOH. MicroMicro techniques, therefore, compared the AcbSh DA response between 
adolescent-EtOH-exposed and -naïve subjects following EtOH administration into the 
pVTA.  
  
 
25 
 
 
 
 
 
 
 
2. METHODS 
 
 
 
Subjects 
 
The adolescent EtOH access procedures used herein followed published 
procedures from our laboratory (Rodd-Henricks et al., 2002a, Bell et al., 2003, 2004, 
2006, Sahr et al., 2004). Male P rats were chosen for use in the current study because 
their rapid growth post-adolescence increases skull strength for earlier cannula 
placement surgery. Previous work (McKinzie et al., 1998a, Bell et al., 2003) has 
described the differences between male and female P rats in EtOH drinking at these 
ages as minimal.  
Animals used in this study were maintained in facilities fully accredited by the 
Association for the Assessment and Accreditation of Laboratory Animal Care. All 
research protocols were approved by the Indiana University School of Medicine 
(Indianapolis, Indiana) Institutional Animal Care and Use Committee and were in 
accordance with the guidelines of the Institutional Care and Use Committee of the 
National Institute on Drug Abuse, the NIH, and the Guide for the Care and Use of 
Laboratory Animals (2011). 
 
Peri-Adolescent EtOH Exposure Procedure 
 
 Pups were single-housed in hanging stainless steel cages (Allentown Caging 
Equipment Co, Allentown, New Jersey) on PD 28. Subjects were initially maintained on 
a 12-hour light/dark cycle, lights on at 0900. On PD 30, subjects received either ad lib 
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water or continuous access to 15% v/v EtOH and water, until PD 60. Food was available 
ad lib. Bottle and body weights for all subjects were recorded every other day.  
On PD 60, EtOH access ceased, and subjects were pair-housed in standard 
shoebox cages, within the same treatment condition. Subjects were also immediately 
transferred to a 12-hour reverse dark/light cycle, lights off at 1000, to optimize rats' 
nocturnal activity levels for later procedures. After PD 60, subjects received no further 
oral EtOH intake experience. 
 
ICSA 
 
 
 
ICSA Apparatus 
 
Test chambers (Coulbourn Instruments, Allentown, Pennsylvania) were situated 
in sound-attenuating cubicles, as described previously (Rodd-Henricks et al., 2000, 
Rodd et al., 2004b). Briefly, chambers were illuminated by dim house lights during 
testing. Two identical levers were mounted on a single wall of the test chamber, 15 cm 
above a grid floor, separated by 12 cm. Directly above each lever were two cue lights, 
red and green. Red was illuminated over the active lever during resting conditions.  
A desktop computer recorded the data (L2T2 system, Coulbourn Instruments, 
Allentown, Pennsylvania) and controlled the operant delivery of infusate following active 
lever response. An electrolytic microinfusion transducer (EMIT) system (Model 26, MNC, 
Shreveport, Louisiana) controlled the delivery of assigned infusate into the subject via 
calibrated pulses of current. To do this, a cylinder (28 mm length x 6 mm diameter; 
Plastics One, Roanoke, Virginia) with an attached 28 gauge injection cannula was filled 
with infusate. Two platinum electrodes extended into the cylinder from an airtight 
enclosure cap. This was connected by a spring-coated cable (Plastics One) and a swivel 
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(Mercotac, Inc.) to a constant current generator (MNC, Shreveport, Louisiana) that 
maintained low quiescent current between the electrodes. Depression of the active lever 
initiated a 5-sec infusion current of 200 µA, resulting in rapid generation of hydrogen 
gas, increasing the pressure inside the airtight cylinder, pressing a 100 nl bolus of 
infusate out through the injection tip. Between infusions, current returned to the low 
quiescent state. 
During each infusion, there was a 5-sec time-out period where bar-press 
responses were recorded yet resulted in no further infusion. In this time-out, the house 
light and a red cue light were extinguished, while the green cue light over the active lever 
flashed in 0.5-sec intervals. The assignment of active and inactive lever with respect to 
the left or right position was counterbalanced among subjects, and remained the same 
throughout the experiment for each respective subject. 
 
ICSA Procedure 
 
Adolescent EtOH treatment occurred as described above. Food and water were 
available ad lib at all times, except during ICSA testing.  
ICSA was performed as previously described (Rodd-Henricks et al., 2000, Rodd 
et al., 2004b). After postnatal day 75, the rats were implanted under isoflurane 
anesthesia with a guide cannula (22 gauge, Plastics One) stereotaxically aimed 1.0 mm 
above the pVTA. Coordinates were 5.8 to 6.1 mm posterior to bregma, 2.1 mm lateral, 
and 8.5 mm ventral from the surface of the skull at a 10 degree angle from the vertical 
(Paxinos and Watson, 1986). A place-holding stylet (28 gauge, Plastics One) extending 
0.5 mm beyond the tip of the guide cannula was inserted at all times, except during test 
sessions. Subjects were single-housed post surgery, and allowed to recover for 7 days. 
Three days prior to testing, subjects were handled 5 min per day. 
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All infusates were prepared freshly on the day of the experiment. Artificial 
cerebrospinal fluid (aCSF) was used as the vehicle for ICSA infusions. This injection 
vehicle consisted of (in mM) 120.0 NaCl, 4.8 KCl, 1.2 KH2PO4, 1.2 MgSO4, 25.0 
NaHCO3, 2.5 CaCl2, and 10.0 D-glucose, all filtered through a sterile filter (pore size 0.2 
µM) as previously described (Rodd-Henricks et al., 2000, Rodd et al., 2004b). Ethyl 
EtOH (190 proof; McCormick Distilling Co., Weston, Missouri) was dissolved in the 
vehicle solution to the correct concentration. When necessary, 0.5 N HCl was added to 
adjust the pH to 7.4 (±0.1). 
ICSA was conducted similar to procedures previously described (Rodd-Henricks 
et al., 2000, Rodd et al., 2004b). Briefly, subjects were brought to the testing room, the 
stylet was removed, and an injection cannula/infusate cylinder was affixed in place. The 
injection cannula extended 1.0 mm beyond the tip of the guide, into the pVTA. A single, 
noncontingent administration of infusate was given at the beginning of the session 
during this insertion procedure in order to prime the system. Test sessions occurred 
every other day. No operant shaping techniques were used. Active lever and inactive 
lever sides were counterbalanced between subjects, remaining the same for each 
individual rat. Within each 4 hr session, responses on the active lever resulted in 5 sec 
infusions on a fixed ratio 1 schedule of reinforcement. During infusion and time-out, 
responses on the active lever were recorded, but did not produce further infusions. 
Responses on the inactive lever were recorded but did not result in infusions at any time; 
these responses were used to index non-specific bar-pressing activity. During ICSA 
sessions 1 through 4 (acquisition), subjects received their respective dose of either the 
aCSF vehicle or EtOH. During ICSA sessions 5 and 6 (extinction), all subjects received 
aCSF vehicle only, and in session 7 (reinstatement), the original concentration was 
made available. 
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MicroMicro 
 
 
 
MicroMicro Apparatus 
 
Experimental housing was composed of Plexiglas chambers (40 x 28 x 40 cm). 
Polyethylene tubing connected to a dedicated Harvard pump (Harvart Apparatus, 
Holliston, Massachusetts) was used to administer aCSF continuously throughout the 
experiment for microdialysis in the AcbSh. The connection to the EMIT unit for 
microinjection administration to the pVTA was identical to that used in the ICSA 
experiment, although automated control of injections was programmed into the unit 
(Isolated Pulse Stimulator Model 2100, A-M Systems Inc, Sequim, Washington), instead 
of the separate computer controlling and recording operant self-administration. 
Microdialysis probes were prepared as approximately 2-mm loop style probes, as 
previously described (Perry and Fuller, 1992, Engleman et al., 2000, Melendez et al., 
2002). Probes were manufactured in the laboratory with regenerated cellulose 
Spectra/Por ® hollow fiber microdialysis tubing, molecular weight cut off of 13,000. In our 
laboratory, these have been previously found to have approximately 15% DA recovery, 
which is an average recovery rate for this design and probe length (Justice, 1993). 
 
MicroMicro Procedure 
 
Adolescent EtOH treatment occurred as in the first experiment. Food and water 
were available ad lib at all times, except during MicroMicro testing. MicroMicro was 
performed as previously described (Ding et al., 2011). After PD 75, and under isoflurane 
anesthesia, a microinjection guide cannula (22 gauge, Plastics One) was implanted in 
the right hemisphere of each subject, stereotaxically aimed 1.0 mm above the pVTA. 
Coordinates were 5.8 to 6.1 mm posterior to bregma, 2.1 mm lateral, and 8.5 mm ventral 
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from the surface of the skull at a 10 degree angle from the vertical (Paxinos and Watson, 
1986). A place-holding stylet (28-gauge, Plastics One) extending 0.5 mm beyond the tip 
of the guide cannula was inserted at all times, except during final experimentation. Also 
in the right hemisphere, a guide cannula (18 gauge, Plastics One) was implanted, aimed 
3.0 mm above the AcbSh. Coordinates were 1.7 mm anterior to bregma, 2.3 mm lateral, 
and 5.4 mm ventral to the surface of the skull at a 10 degree angle from the vertical 
(Paxinos and Watson, 1986). A place-holding stylet (Plastics One) extending 0.5 mm 
was inserted at all times, except during final experimentation.  
Subjects were single-housed post surgery, and allowed to recover 6 days. Three 
days prior to testing, subjects were habituated to the testing chambers, 3 hours per day. 
One day before testing, microdialysis probes were inserted into the AcbSh under 
isoflurane anesthesia. When inserted, the dialyzing loop was oriented in an anterior-
posterior direction to maximize exposure to the AcbSh. The probe extended 3 mm below 
the guide cannula, into the AcbSh.  
The next day, the MicroMicro procedure was performed. Subjects were placed in 
the experimental chambers and the microdialysis probe tubing was connected to the 
pump for aCSF perfusion. The aCSF microdialysis perfusion medium was composed (in 
mM) as has been previously described (Melendez et al., 2002) of 145.0 NaCl, 2.7 KCl, 
1.0 MgCl2, 2.5 CaCl2, and 2.0 Na2HPO4, filtered through a sterile filter (pore size 0.2 
µM), always prepared fresh the day of the procedure. When necessary, pH was adjusted 
to 7.4 with 0.1 N acetic acid. Perfusate aCSF formula differed from injection aCSF to 
maximize diffusion across the probe dialysis membrane. 
Flow speed of the perfusion medium was 1 µL/min. Microdialysis outflow was 
collected for 15 min per sample. After at least 90 min of washout flow, at least three 
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baseline dialysate samples were collected. This was followed by one microinjection 
dialysate sample.  
During the microinjection sample, the pVTA-cannula stylet was removed and the 
injection cannula/infusate cylinder affixed in place. The injection cannula extended 1.0 
mm beyond the tip of the guide, into the pVTA. Administration of infusate occurred 
automatically, as programmed into the EMIT machine. Each subject received 
microinjections of one solution only, prepared identically to that in the ICSA experiment; 
either infusate vehicle aCSF, or 50, 75, 100, or 200 mg% EtOH. All subjects received the 
same volume of microinjections. Microinjections were composed of a series of 100 nL 
boluses, each delivered over an interval of 5 sec. This was repeated every 20 sec for a 
total of 30 microinjections over a 10 min period into the pVTA.  
Following the microinjection sample, 120 min of post-injection dialysate samples 
were collected. All samples were collected into tubes containing preservative of 5 µL of 
0.1 N perchloric acid. After collection, samples were immediately frozen on dry ice and 
stored at -70 degrees C until HPLC analysis for DA content. 
 
HPLC Apparatus 
 
All microdialysis samples were analyzed with microbore HPLC-EC to determine 
extracellular levels of DA. Stored as described at -70 degrees C, there is no degradation 
of the DA samples (Campbell and McBride, 1995). Samples were loaded into a 10 µL 
sample loop and injected onto an analytical column. Detector output ran to a computer 
program for analysis (ChromPerfect, Justice Innovations, Inc., Palo Alto, California). DA 
levels were then determined by comparison with a standard curve. The lower sensitivity 
limit for DA was estimated to be 0.1 nM. 
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Histologies 
 
 Upon termination of ICSA experiments, a solution of 1% bromophenol blue dye 
was injected into the infusion site and the animals sacrificed. Brains were removed and 
immediately frozen at -70 degrees C, for slicing into 40-µm sections with a cryostat 
microtome. Slides were stained with cresyl violet and examined for infusion site 
verification using the atlas of Paxinos and Watson (1986).  
 Upon termination of MicroMicro experiments, a 1% bromophenol blue dye was 
injected into the infusion site and perfused through the microdialysis probe, and the 
animals were sacrificed. Brains were removed and immediately frozen at -70 degrees C, 
for slicing into 40-µm sections with a cryostat microtome. Slides were stained with cresyl 
violet and examined for infusion and microdialysis site verification using the atlas of 
Paxinos and Watson (1986). 
 
Statistical Analysis 
 
EtOH consumption was analyzed as pure EtOH intake (grams of EtOH per 
kilogram of body weight, g/kg). Change in preference ratio for EtOH intake vs. water was 
calculated by plotting ratios each day of EtOH exposure as a percentage of 15% EtOH 
solution consumed in relation to total fluids consumed ([g ethanol solution intake/g 
ethanol solution intake + g water intake] x 100). The first day of access was compared to 
the last day of access. Intake and Preference data were averaged in six blocks of 5 
days, analyzed with a repeated measures ANOVA and linear regression between 
blocks. 
ICSA data were analyzed with a Dose x Session mixed ANOVA, with repeated 
measures on Session performed on the number of active lever responses and the 
number of infusions separately. For each individual group, lever discrimination was 
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determined by "lever (active vs. inactive) x session" mixed ANOVA with repeated 
measures on session. Post hoc Tukey’s b tests were employed when a significant main 
effect was found, p < 0.05. Extinction was determined by comparing the responses on 
the active lever during sessions 4, 5, and 6, while reinstatement was determined by 
comparing the responses on the active lever during sessions 5, 6, and 7. 
MicroMicro data were expressed as a percentage of basal DA values, to correct 
for between-subject baseline variability, as previously described (Engleman et al., 2006). 
Basal dialysate values for each subject were calculated as the mean of three baseline 
samples prior to the injection sample. Also, absolute levels of baseline DA were 
calculated, and compared as group means between the two peri-adolescent Exposure 
Groups. The effects of peri-adolescent EtOH administration on basal extracellular DA 
levels and maximal drug effect with each Dose was calculated using Student’s t-test. 
The effects of EtOH microinjection administration on extracellular DA levels as a function 
of time and adolescent treatment condition were analyzed using a two-way Adolescent 
Group x Time analysis of variance (ANOVA), with repeated measures on Time (15-min 
samples), followed by the Tukey's post hoc test. Alpha was set at a P < 0.05 significance 
level. 
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3. RESULTS 
 
 
 
Cannula Placements 
 
 ICSA injector placements (Figure 1) located in the pVTA ranged from AP -5.5 to 
AP -6.1 mm relative to bregma as illustrated in 
Rat Brain in Stereotaxic Coordinates (Paxinos 
and Watson, 1986). Only subjects with the 
injector tip entirely within the pVTA (Rodd-
Henricks et al., 2000) were used in the study. 
Prior to surgery, there were 104 peri-adolescent 
EtOH-exposed and 83 naïve subjects for the 10 
groups of ICSA. After histologies, 69 total 
subjects were included in data analyses. Most 
misplaced guide cannulas aimed at the aVTA. 
 MicroMicro injector placements located in 
the pVTA (Figure 1) ranged from AP -5.5 to AP -
6.1 mm relative to bregma. Only data from 
animals with the injector tip entirely within the 
pVTA (Rodd-Henricks et al., 2000) were used 
in the analyses. Microdialysis probe 
placements (Figure 2) ranged from AP 1.5 to 
Figure 1. ICSA and MicroMicro Injector 
Placement. Top: Representation of 
placement sites within the pVTA. Black 
squares indicate representative locations 
of injection sites within the pVTA. Figure 
adapted from Paxinos and Watson 
(1986). Bottom: Depicts a photo of a 
representative brain slice, injection tip 
within the pVTA.  
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AP 1.7, and were located mainly in the AcbSh. 
Only animals with at least 75% of the 
microdialysis probe within the AcbSh were used 
in the analyses. Prior to surgery, there were 72 
peri-adolescent EtOH-exposed and 56 naïve 
subjects for the 10 groups of MicroMicro. After 
histologies, 50 total subjects were included in 
data analyses. A large majority of AcbSh cannulas 
were correctly placed. Most missed pVTA cannulas 
were aimed either in the red nucleus or below the 
pVTA. 
 
Body Weights 
 
For body weight data illustration 
purposes, data were sampled every 4 days of the 
exposure period. There was a significant main 
effect of day (F7,96 = 1370.7, p < 0.001), but 
no significant main effect of exposure group 
(F1,102= 0.257, p=0.613). There was no 
significant day x exposure group interaction 
(F7,96 = 1.53, p=0.167). This shows that 
while subjects gained body weight 
throughout the peri-adolescent time period, 
the EtOH-Exp  
Figure 3. Body weights ICSA. Mean body 
weights (±SEM) over the 30 day peri-
adolescent period for Naïve and free-choice 
EtOH-exposed (EtOH-Exp) subjects in the 
ICSA experiment. There was no significant 
difference between exposure groups. 
 
Figure 2. MicroMicro Dialysis Probe 
Placement.Top: Representation of 
placement sites within the AcbSh. 
Lines indicate representative locations 
of active probe in the AcbSh. Figure 
adapted from Paxinos and Watson 
(1986). Bottom: Depicts a photo of a 
representative brain slice, active 
probe membrane area within the 
AcbSh. 
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and Naïve subjects did not differ from each other in bodyweight within the ICSA or 
MicoMicro experiments (Figures 3 and 4).  
 
Peri-Adolescent EtOH Consumption and EtOH Preference 
 
 Initial consumption for all peri-
adolescent EtOH-exposed subjects was 5.17 
±0.36 g/kg/day. At the end of the access 
period, consumption was 7.80 ±0.31 
g/kg/day.  
For illustration of peri-adolescent 
EtOH consumption purposes, data (g/kg/day) 
were averaged in six blocks of 5 days. The 
repeated measures within subjects ANOVA 
revealed there was a significant main effect of 
Day (F5,51 = 5.627, p < 0.001), indicating 
that EtOH consumption changed over 
time. There was no significant effect of 
Study Group (F1, 55 = 1.948, p = 0.168).  
There was no significant Day x 
Study Group interaction (F5,51 = 0.582, 
p = 0.713). Given this lack of difference 
between study groups, peri-adolescent 
EtOH consumption data were collapsed 
across all EtOH-drinking subjects, for a total 
N of 176 animals. With these data the EtOH 
Figure 4. Body weights MicroMicro. Mean 
body weights (±SEM) over the 30 day peri-
adolescent period for Naïve and free-choice 
EtOH-exposed (EtOH-Exp) subjects in the 
MicroMicro experiment. There was no 
significant difference between exposure 
groups. 
Figure 5. EtOH Intake. Represents the mean 
EtOH intake data for 15% v/v EtOH, g/kg. 
There was no significant difference between 
experimental groups. Differences over time 
are illustrated in the Appendix. 
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consumption average of each block of 5 days was compared to the other blocks of 5 
days with paired samples T-tests. Every single block was significantly different from 
block 1 (M = 5.13, SEM = 0.29); block 2 (M = 6.13, SEM = 0.33, t(175)=-3.70, p < 
0.001), block 3 (M = 7.56, SEM = 0.36, t(175)=-6.71, p < 0.001), block 4 (M = 8.27, SEM 
= 0.37, t(175)=-7.74, p < 0.001), block 5 (M = 8.54, SEM = 0.36, t(175)=-8.33, p < 0.001) 
and block 6 (M = 8.05, SEM = 0.31, 
t(175)=-7.21, p < 0.001). Block 2 was 
significantly different from block 3 
(t(175)=-4.80, p < 0.001), block 4 
(t(175)=-5.75, p < 0.001), block 5 
(t(175)=-5.93, p < 0.001), and block 6 
(t(175)=-4.85, p < 0.001). Block 3 was 
significantly different from block 4 
(t(175)=-2.14, p = 0.03), but not block 5 
(t(175)=-2.62, p = 0.09) or block 6 
(t(175)=-1.27, p = 0.20). Block 4 was not 
significantly different from block 5 (t(175)=-1.29, p = 0.19) or block 6 (t(175)=0.632, p = 
0.528), nor was block 5 significantly different from block 6 (t(175)=1.789, p = 0.07).  
These results indicate that EtOH intake increased over 5-day blocks, until block 
4. This further suggests that EtOH consumption increase over time to a plateau between 
blocks 3 and 4, essentially the midpoint of EtOH access, whereupon amount of EtOH 
intake continued at prior levels and did not change. 
For illustration of peri-adolescent EtOH Preference purposes, data (calculated by 
g 15% EtOH/g total fluids) were averaged in 6 blocks of 5 days. Following a within 
subjects repeated measures ANOVA for 5 day EtOH Preference blocks, there was a 
Figure 6. EtOH Preference. Represents the 
mean EtOH preference data for 15% v/v EtOH 
compared to water, as expressed in grams of 
fluid. There was no significant difference 
between experimental groups. Differences over 
time are illustrated in the Appendix. 
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significant main effect of Block (F5,54 = 31.576), indicating that EtOH Preference changed 
over time. There was no significant effect of Study Group (F1, 58 = 0.625, p = 0.433). 
There was no significant Block x Study Group interaction (F5,54 = 0.822, p = 0.540).  
Given this lack of difference between study groups, peri-adolescent EtOH 
Preference data were collapsed across all EtOH-drinking subjects, for a total N of 176 
animals. This data was then used to compare the EtOH Preference average of each  
block of 5 days to the other blocks of 5 days with paired samples T-tests. Every single 
block was significantly different from block 1 (M = 18.09, SEM = 1.17); block 2 (M = 
21.92, SEM = 1.04, t(175)=-3.91, p < 0.001), block 3 (M = 28.83, SEM = 1.17, t(175)=-
9.31, p < 0.001), block 4 (M = 35.82, SEM = 1.18, t(175)=-13.48, p < 0.001), block 5 (M 
= 39.68, SEM = 1.16, t(175)=-15.44, p < 0.001) and block 6 (M = 42.77, SEM = 1.08, 
t(175)=-17.46, p < 0.001). Block 2 was significantly different from block 3 (t(175)=-10.16, 
p < 0.001), block 4 (t(175)=-13.90, p < 0.001), block 5 (t(175)=-16.50, p < 0.001), and 
block 6 (t(175)=-18.88, p < 0.001). Block 3 was significantly different from block 4 
(t(175)=-8.55, p < 0.001), block 5 (t(175)=-10.99, p < 0.001), and block 6 (t(175)=-12.56, 
p < 0.001). Block 4 was significantly different from block 5 (t(175)=-5.87, p < 0.001) and 
block 6 (t(175)=7.28, < 0.001). Block 5 was also significantly different from block 6 
(t(175)=4.26, p < 0.001). These results suggest that EtOH Preference versus water 
consistently increased over time. 
 Taken together, the results suggest that while EtOH total amount in g/kg 
plateaued at approximately 15 days of access, EtOH Preference continued to increase 
throughout the exposure period.  
The Appendix shows visual expression of total EtOH intake data blocks and 
preference data blocks in predictive linear regression scatter plots of individual rats’ 
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consumption at multiple paired time points, as well as proportion of explained variance 
(r2 ) calculated from their associated Pearson’s r correlation coefficients.  
 
ICSA 
 
Comparison of average acquisition responding during the first four days of ICSA 
with a between-subjects ANOVA revealed a significant main effect of Exposure Group 
(F1,68 = 12.42, p = 0.001), a significant main effect of Dose (F4,68 = 8.43, p < 0.001), and 
an Exposure Group by Dose interaction (F5,51 = 3.70, p = 0.009). 
In peri-adolescent exposed subjects, a one-way ANOVA with Tukey’s b post-hoc 
test was performed to compare acquisition responding by Dose to Infusion, Active Lever, 
and Inactive Lever data. There was a significant effect of Dose on Infusions (F4,33 = 8.63, 
p < 0.001) and a significant effect of Dose on Active Lever (F4,33 = 7.43, p < 0.001), but 
no significant effect of Dose on Inactive Lever (F4,33 = 2.04, p = 0.114). 
Post-hoc comparison by Tukey’s b tests (which corrects for unequal sample size) 
revealed that peri-adolescent exposed subjects bar-pressing for ICSA in adulthood of 
75, 100, and 150 mg% EtOH, significantly (p < 0.05 level) infused these doses at a 
higher rate than both aCSF and 50 mg%. Also, similar analysis of bar-presses on the 
Active Lever by this group revealed significance at a 0.05 level for increased responding 
for 75, 100, and 150 mg% EtOH compared to aCSF and 50 mg%. There were no 
significant differences in response between doses on the Inactive Lever. 
In naive subjects, a one-way ANOVA with Tukey’s b post-hoc test was performed 
to compare acquisition responding by Dose to Infusion, Active Lever, and Inactive Lever 
data. There was a significant effect of Dose on Infusions (F4,34 = 2.70, p = 0.049) and a 
significant effect of Dose on Active Lever responses (F4,34 = 2.91, p = 0.037), but no 
significant effect of Dose on Inactive Lever responses (F4,34 = 1.50, p = 0.226). 
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Post-hoc comparison by 
Tukey’s b tests revealed that naive 
subjects bar-pressing for ICSA of 150 
mg% EtOH, significantly infused this 
dose at a higher rate than aCSF, 50, 
75, and 100 mg% EtOH (Figure 6). 
Also, similar analysis of bar-presses 
on the Active Lever by this group 
revealed significance at a 0.05 level for 
increased responding for 150 mg% 
EtOH only compared to aCSF, 50, 75, 
and 100 mg% EtOH. There were no 
significant differences in response between doses on the Inactive Lever. 
 One-way ANOVAs were performed for each Dose. For aCSF, there was no 
significant difference between EtOH-exposed and naïve subjects for Infusion (F1,11 = 
2.42, p = 0.150), Active Lever (F1,11 = 0.96, p = 0.350), or Inactive Lever (F1,11 = 0.06, p = 
0.806). For 50 mg% EtOH, there was no significant difference between EtOH-exposed 
and naïve subjects for Infusion (F1,19 = 0.79, p = 0.386), Active Lever (F1,19 = 0.50, p = 
0.485), or Inactive Lever (F1,19 = 0.003, p = 0.954). For 75 mg% EtOH, there was a 
significant difference between EtOH-exposed and naïve subjects for Infusion (F1,16 = 
14.23, p = 0.002) and Active Lever (F1,16 = 19.94, p < 0.001), but no significant difference 
of Inactive Lever (F1,16 = 0.15, p = 0.704). For 100 mg% EtOH, there was a significant 
difference between EtOH-exposed and naïve subjects for Infusion (F1,9 = 8.18, p =  
Figure 7. ICSA: Mean Acquisition Infusions. 
Average infusions (±SEM) by male P rats for self-
infusion of aCSF, 50, 75, 100, or 150 mg% EtOH 
during the first four sessions, into the p-VTA. 
Asterisks indicate infusions were significantly 
different from aCSF, p < 0.05. Pound signs 
indicate infusions by peri-adolescent EtOH-
exposed subjects (EtOH-Exp) were significantly 
different from naïve subjects, p <0.05.  
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0.021) and Active Lever (F1,9 = 6.89, p = 0.030), but no significant difference of Inactive 
Lever (F1,16 = 0.006, p = 0.940). Finally, for 150 mg% EtOH, there was no significant 
difference between EtOH-exposed and naïve subjects for Infusion (F1,9 = 0.49, p = 
0.503), Active Lever (F1,9 = 1.397, p = 0.271)., or Inactive Lever (F1,9 = 0.05, p = 0.821).  
A repeated measures within-factor multivariate test was then performed for all 
groups. The repeated measure was Session, with a between subject comparison of 
Dose by Exposure Group. There was a main effect of Session (F6,54 = 12.65, p < 0.001), 
a Session by Exposure Group interaction (F6,54 = 3.02, p = 0.013), a Session by Dose 
interaction (F24,228 = 2.11, p = 0.003), and a Session by Exposure Group by Dose 
interaction (F24,228 = 2.15, p = 0.002). 
 Within peri-adolescent EtOH-exposed 
subjects, there was a significant effect of session 
(F6,24 = 8.01, p < 0.001) and a significant interaction 
of Session by Dose (F24,108 = 1.95, p = 0.011). 
Because there is a significant interaction, we break 
down one-way ANOVAs over the sessions. There 
is a significant difference for Session 1 (F4,33 = 4.03, 
p = 0.010), Session 2 (F4,33 = 12.01, p < 0.001), 
Session 3 (F4,33 = 3.89, p = 0.012), Session 4 (F4,33 
= 6.79, p = 0.001), and Session 7 (F4,33 = 12.86, p < 
0.001), but not Session 5 (F4,33 = 2.46, p = 0.067) or 
Session 6 (F4,33 = 1.54, p = 0.216). This is an 
indication of extinction, where significant difference 
does not appear between Doses on Sessions 5 and 6 (Figures 7 through 11).  
Figure 8. ICSA: aCSF Levers. Mean 
responses (±SEM) on the active and 
inactive lever by male P adolescent 
naïve (top) and E-Exposed (bottom) 
rats for self-infusion of aCSF. There 
was no significant difference between 
the two groups. 
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Within naive subjects, there was a significant effect of session (F6,25 = 6.67, p < 
0.001) and a significant interaction of Session by Dose (F24,112 = 2.46, p = 0.001). 
Because there is a significant interaction, one-way ANOVAs are broken down over the 
sessions. There is a significant difference for Session 3 (F4,34 = 3.32, p = 0.023) and 
Session 4 (F4,34 = 4.42, p = 0.006). There was no 
significant difference for Session 1 (F4,34 = 0.473, p 
= 0.755), Session 2 (F4,34 = 1.12, p = 0.364), 
Session 5 (F4,34 = 2.25, p = 0.087), Session 6 (F4,34 
= 1.86, p = 0.143), or Session 7 (F4,34 = 2.16, p = 
0.098). 
To determine presence (or lack) of lever 
discrimination in naïve subjects, a repeated 
measure analysis of Lever was examined, with a 
between subjects comparison of Dose and 
Exposure Group. There was no interaction of 
Session by Lever by Exposure Group (F24,112 = 
1.07, p = 0.384). This was followed with paired-
sample t-tests of both levers at each dose. Among 
naïve subjects at the 150 mg% dose, there was no observed lever discrimination (p = 
0.140 and greater). Among peri-adolescent EtOH-Exposed subjects at the 75 mg% 
dose, there was lever discrimination on Session 1 (p = 0.022), Session 2 (p = 0.007), 
Session 3 (p = 0.022), Session 4 (p = 0.004) and Session 7 (p = 0.011). Among peri-
adolescent EtOH-Exposed subjects at the 100 mg% dose, there was lever discrimination 
on Session 1 (p = 0.002), Session 2 (p = 0.029), Session 4 (p = 0.017) and Session 7 (p 
= 0.001). Among peri-adolescent EtOH-Exposed subjects at the 150 mg% dose, there 
Figure 9. ICSA: 50 mg% Levers. Mean 
responses (±SEM) on the active and 
inactive lever by male P adolescent naïve 
(top) and E-Exposed (bottom) rats for 
self-infusion of 50 mg% EtOH. Sessions 
5 and 6 were vehicle only. There was no 
significant difference between the two 
groups. 
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was lever discrimination on Session 2 (p = 
0.22), Session 4 (p = 0.043) and Session 7 
(p = 0.019). 
 When focusing on extinction data of 
the peri-adolescent EtOH-exposed subjects, 
repeated measures analysis with 3 sessions 
included (Sessions 4, 5, and 6) was 
examined for concentrations that supported 
infusions. There was a significant 
effect of Session (F2,28 = 12.88, p 
< 0.001) and a significant Session 
by Dose interaction (F8,58 = 2.11, p 
= 0.048). The interaction term was 
decomposed by examining 
Session for each Dose level, including 
follow-up t-tests. In EtOH-exposed subjects 
that were given 75 mg% EtOH to self-
administer, the number of infusions during 
sessions 4 was significantly higher than 
session 5 (p = 0.05) and session 6 (p = 
0.05). In EtOH-exposed subjects that were 
given 100 mg% EtOH to self-administer, the 
number of 
infusions 
Figure 10. ICSA: 75 mg% Levers. Mean responses (±SEM) 
on the active and inactive lever by male P adolescent naïve 
(top) and E-Exposed (bottom) rats for self-infusion of 75 
mg% EtOH. Sessions 5 and 6 were vehicle only. Asterisk 
(*) indicates lever discrimination and significant difference of 
E-Exp from naïve group, p < 0.05. Carat (^) indicates 
significant difference from extinction session 5, Pound sign 
(#) indicates significant difference from extinction sessions 
5 and 6. 
 
 
Figure 11. ICSA: 100 mg% Levers. Mean responses (±SEM) on the active and 
inactive lever by male P adolescent naïve (top) and E-Exposed (bottom) rats for 
self-infusion of 100 mg% EtOH. Sessions 5 and 6 were vehicle only. Asterisk (*) 
indicates lever discrimination, p < 0.05. Carat (^) indicates significant difference 
from extinction sessions and significant difference of E-Exp from naïve group. 
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during session 4 was significantly higher than session 6 (p = 0.015), while the difference 
between 4 and 5 approached significance (p = 0.67). In EtOH-exposed subjects that 
were given 150 mg% EtOH to self-administer, there was no significant difference 
between sessions 4 and 5 or 4 and 6 (p = 0.27 and 0.34). 
 Active lever data were also used for 
analysis of extinction data of peri-adolescent 
EtOH-exposed subjects. Repeated measures 
analysis revealed a significant main effect of 
Session (F2,28 = 11.85 p < 0.001) and a 
significant Session by Dose interaction (F8,58 = 
2.95, p = 0.008). The interaction term was 
decomposed by examining Session for each 
Dose level, including follow-up t-tests. In EtOH-
exposed subjects that were given 75 mg% 
EtOH to self-administer, the number of active 
lever responses during sessions 4 was 
significantly higher than session 5 (p = 0.004) 
and session 6 (p = 0.010). In EtOH-exposed 
subjects that were given 100 mg% EtOH to 
self-administer, the number of active lever 
responses during session 4 was significantly higher than session 5 (p = 0.018), as well 
as 6 (p = 0.14). In EtOH-exposed subjects that were given 150 mg% EtOH to self-
administer, there was no significant difference between sessions 4 and 5 or 4 and 6 (p = 
0.22 and 0.18). 
Figure 12. ICSA ICSA 150 mg% Levers. Mean 
responses (±SEM) on the active and inactive 
lever by male P adolescent naïve (top) and E-
Exposed (bottom) rats for self-infusion of 150 
mg% EtOH. Sessions 5 and 6 were vehicle only. 
Asterisk (*) indicates lever discrimination, p < 
0.05. There was no significant difference of E-
Exp from naïve group. Carat (^) indicates 
significant difference from extinction session 5. 
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When focusing on reinstatement data of the peri-adolescent EtOH-exposed 
subjects, repeated measures analysis with 3 sessions included (sessions 5, 6, and 7) 
was examined for concentrations that had previously supported infusions. There was a 
significant effect of Session (F2,28 = 22.63, p < 0.001) and a significant Session by Dose 
interaction (F8,58 = 3.37, p = 0.003). The interaction term was decomposed by examining 
Session for each Dose level, including follow-up t-tests. In EtOH-exposed subjects that 
were given 75 mg% EtOH to self-administer, the number of infusions during session 5 
was significantly lower than session 7, (p = 0.020) as was 6 (p = 0.024). In EtOH-
exposed subjects that were given 100 mg% EtOH to self-administer, the number of 
infusions during session 5 was significantly lower than session 7, (p = 0.003) as was 6 (p 
< 0.001). In EtOH-exposed subjects that were given 150 mg% EtOH to self-administer, 
there was no significant difference between session 5 and 7 or 6 and 7 (p = 0.213 and 
0.142).  
Active lever data were also used for analysis of reinstatement data of peri-
adolescent EtOH-exposed subjects. Repeated measures analysis revealed a significant 
main effect of Session (F2,28 = 16.91, p < 0.001) and a significant Session by Dose 
interaction (F8,58 = 3.88, p = 0.001). The interaction term was decomposed by examining 
Session for each Dose level, including follow-up t-tests. In EtOH-exposed subjects that 
were given 75 mg% EtOH to self-administer, the number of active lever responses 
during sessions 5 was significantly lower than session 7 (p = 0.008) as was session 6 (p 
= 0.034). In EtOH-exposed subjects that were given 100 mg% EtOH to self-administer, 
the number of active lever responses during session 5 was significantly lower than 
session 7 (p = 0.001), as was 6 (p = 0.001). In EtOH-exposed subjects that were given 
150 mg% EtOH to self-administer, there was no significant difference between active 
lever responses for sessions 5 and 7 or 6 and 7 (p = 0.207 and 0.154). 
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When focusing on extinction data of the naive subjects, repeated measures 
analysis with 3 sessions included (Sessions 4, 5, and 6) was examined for the one 
concentration that supported infusions. There was a no significant effect of Session (F2,29 
= 2.45, p = 0.103) but there was a significant Session by Dose interaction (F8,60 = 4.73, p 
< 0.001). The interaction term was decomposed by examining Session for one Dose 
level, including follow-up t-tests. In naïve subjects that were given 150 mg% EtOH to 
self-administer, the number of infusions during session 4 was significantly higher than 
session 5 (p = 0.040) and 6 (p = 0.023).  
Active lever data were also used for analysis of extinction data of naïve subjects. 
Repeated measures analysis revealed a significant main effect of Session (F2,29 = 4.59 p 
= 0.019) and a significant Session by Dose interaction (F8,60 = 3.05, p = 0.006). 
The interaction term was decomposed by examining Session for each Dose level, 
including follow-up t-tests. In naive subjects that were given 150 mg% EtOH to self-
administer, there was no significant difference between sessions 4 and 5 (p = 0.063) but 
there was a significant difference between 5 and 6 (p = 0.012). 
When examining reinstatement data of the naïve subjects, repeated measures 
analysis with 3 sessions included (sessions 5, 6, and 7) was examined for the one 
concentration that had previously supported infusions. There was a significant effect of 
Session (F2,29 = 9.214, p = 0.001) and a significant Session by Dose interaction (F8,60 = 
2.76, p = 0.012). The interaction term was decomposed by examining Session for each 
Dose level, including follow-up t-tests. In naïve subjects that were given 150 mg% EtOH 
to self-administer, the number of infusions during session 5 was significantly lower than 
session 7, (p = 0.001) but the same was not seen of 6 and 7 (p = 0.160). 
Active lever data were also used for analysis of reinstatement data of naïve 
subjects. Repeated measures analysis revealed a significant main effect of Session 
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(F2,29 = 5.88, p = 0.007) and a significant Session by Dose interaction (F8,60 = 2.10, p = 
0.05). The interaction term was decomposed by examining Session for each Dose level, 
including follow-up t-tests. In naïve subjects that were given 150 mg% EtOH to self-
administer, the number of active lever responses during session 5 was significantly 
lower than session 7, (p = 0.048) but the same was not seen of 6 and 7 (p = 0.196). 
 
MicroMicro 
 
 Absolute baseline DA levels of 
adolescent experimental groups did not differ 
statistically between groups. Naïve subjects had 
an average baseline DA level of 1.10 (±0.12) 
nM, while EtOH-Exp subjects had an average 
baseline of 1.09 (±0.11) nM (Figure 13). 
 A between-subjects ANOVA revealed 
significant main effect of Time (F11,30 = 3.895, p 
= 0.001) , a significant interaction of Time and Exposure Group (F11,30 = 2.412, p = 
0.027), a significant interaction of Time and Dose (F44,116 = 1.69, p = 0.013), and a 
significant interaction of Time and Dose and Exposure group (F11,33 = 3.31, p = 0.004).  
To decompose the significant 3-way interaction, the initial variable held constant 
was adolescent exposure. Performing a similar repeated measures ANOVA in animals 
that were adolescent naïve, there was a significant Time x Dose interaction (F11,14 = 
6.84, p = 0.001). This significant 2-way interaction term was further reduced by 
examining the effect of dose at each time point. For naïve subjects, there was a 
significant difference at 15 min (F4,25 = 4.57, p = 0.008), 30 min (F4,25 = 7.64, p = 0.001), 
and 60 min (F4,25 = 3.776, p = 0.018). Significance was approached at the 75 min time 
Figure 13. MicroMicro: Absolute DA 
Levels. Mean absolute DA levels 
between adolescent exposure groups. 
There was no significant difference 
between the two groups. 
 
48 
 
point (p = 0.057). Post hoc tests 
performed for each individual time 
point (SNK and Tukey’s b) indicated 
that in the 15 to 30 min post-injection 
block that the 150 mg% group was 
significantly different from the aCSF 
and 50 mg% group, with no other 
group differences. At the 30 min time 
point, the 150 mg% group was 
significantly different from all other dose 
levels. At the 60 min time point, the 150 mg% group was significantly different from the 
50 mg% dose, but no other levels. Follow-up t-tests showed that in naïve subjects 
receiving the 150 mg% dose microinjection, DA levels at 15 min post injection were 
significantly different compared to baseline (p = 0.004), as was 30 min (p = 0.014). The 
60 min time point approached significance (p = 0.057) (Figures 14 through 18). 
 Performing a repeated 
measures ANOVA in animals that 
were peri-adolescent EtOH exposed, 
there was a significant main effect of 
Time (F9,11 = 4.87, p = 0.012) and 
significant Time x Dose interaction 
(F11,12 = 428, p = 0.009). This 
significant 2-way interaction term 
was further reduced by examining the 
Figure 14. MicroMicro: aCSF. Microdialysis for DA 
(percent baseline, ±SEM) with concurrent pulsed 
microinjection of aCSF. There was no significant 
difference between the two peri-adolescent 
exposure groups, nor from baseline. 
 
Figure 15. MicroMicro: 50 mg% Microdialysis for DA 
(percent baseline, ±SEM) with concurrent pulsed 
microinjection of 50 mg% EtOH. There was no 
significant difference between the two peri-
adolescent exposure groups, nor from baseline. 
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effect of dose at each time point. For 
EtOH-exposed subjects, there was a 
significant difference at the Injection 
time point (F4,23 = 4.25, p = 0.013), 30 
min (F4,23 = 5.23, p = 0.005), 60 min 
(F4,23 = 3.88, p = 0.018), and 90 min 
(F4,23 = 3.69, p = 0.022). Significance 
was approached at the 15 min time 
point (p = 0.078). Post hoc tests 
performed for each individual time 
point (SNK and Tukey’s b) indicated 
that in the Injection time point, the 75 
mg% group was significantly different 
from the aCSF and 50 mg% group, 
with no other group differences. At the 
30 min time point, the 150 mg% group 
was significantly different from the 
aCSF and 50 mg% groups, with no 
other group differences. At the 90 min 
time point, the 150 mg% group was 
significantly different from the aCSF, 50, and 75 mg% groups, with no other group 
difference.  
Follow-up t-tests showed that in peri-adolescent EtOH-exposed subjects 
receiving the 75 mg% dose microinjection, DA levels at the injection time point were 
significantly different compared to baseline (p = 0.029), while 15 min approached 
Figure 16. MicroMicro: 75 mg% Microdialysis for 
DA (percent baseline, ±SEM) with concurrent 
pulsed microinjection of 75 mg% EtOH. Asterisk (*) 
indicates a significant difference from baseline in 
the EtOH-Exp group (p < 0.05).  
Figure 17. MicroMicro: 100 mg% Microdialysis for 
DA (percent baseline, ±SEM) with concurrent 
pulsed microinjection of 100 mg% EtOH. Asterisk 
(*) indicates a significant difference from baseline 
in the EtOH-Exp group (p < 0.05).  
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significance (p = 0.065). In peri-adolescent subjects receiving the 100 mg% dose 
microinjection, DA levels at the injection time point (p = 0.005), 15 min (p = 0.027), 30 
min (p = 0.011), 45 min (p = 0.042), and 60 min (p = 0.011) time points were significantly 
different compared to baseline. In peri-adolescent subjects receiving the 150 mg% dose 
microinjection, DA levels at the injection time point (p = 0.006), 30 min (p = 0.048), and 
60 min (p = 0.007) time points were significantly different compared to baseline.  
 Performing a repeated 
measures ANOVA with a between 
subjects factor of Dose for the last 
baseline and first four post-baseline 
periods, at Dose levels of aCSF, 50, 
and 75 mg% EtOH, there are no 
significant differences between the 
adolescent exposure groups. There is 
a significant difference at 100 mg%, 
with a main effect of time (F4,4 = 8.18, p 
= 0.033) and a Time by Adolescent 
Group (F4,4 = 7.61, p = 0.037). A one-
way ANOVA show that at this time point there is a significant difference at the Injection 
time point (F1,8 = 6.19, p = 0.042), 15 min (F1,8 = 29.69, p = 0.001), 30 min (F1,8 = 8.35, p 
= 0.023), 60 min (F1,8 = 15.56, p = 0.006), and 90 min (F1,8 = 5.91, p = 0.045). The 75 min 
time point approached significance (p = 0.055). There was a significant difference at 150 
mg%, with a main effect of Time (F4,6 = 6.25, p = 0.025) but no interaction. This suggests 
that at 150 mg%, both Adolescent groups increased from baseline. 
Figure 18. MicroMicro: 150 mg% Microdialysis for 
DA (percent baseline, ±SEM) with concurrent 
pulsed microinjection of 150 mg% EtOH. Asterisk 
(*) indicates a significant difference from baseline 
in the EtOH-Exp group (p < 0.05). Pound sign (#) 
indicates a significant difference from baseline in 
the Naïve group (p < 0.05). 
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4. DISCUSSION 
 
 
 
 The most salient results emerging from these experiments indicate that P rats given 
free-choice access to EtOH during peri-adolescence will voluntarily consume significant 
amounts of EtOH, and this early developmental drinking experience increases the 
reinforcing properties of EtOH in adulthood. The pVTA, a brain area known to be an 
important target area for EtOH’s reinforcing effects, was found to manifest increased 
sensitivity to EtOH as a consequence of the adolescent drinking experience. This 
suggests that activation pVTA DA cell bodies of the mesolimbic DA system is a critical 
substrate that mediates the reinforcing properties of EtOH, and neuroadaptations in the 
pVTA apparently mediate the enhanced reinforcing actions of EtOH seen in adult 
animals exposed to EtOH during the adolescent period. Additionally, the findings of 
increased sensitivity in the mesolimbic system were confirmed with the observation that 
peri-adolescent EtOH exposure significantly increased DA efflux in the AcbSh, a primary 
terminal region for the pVTA axonal projections. Overall, the findings support the 
overarching hypothesis that peri-adolescent EtOH-exposure produces long-lasting 
alterations in neural circuitry involved in EtOH-reinforcement. 
The findings of this study may have relevant translational impact for the 
importance of adolescent consumption in humans. Adolescent alcohol use appears to be 
experiencing a slight decline over the past two decades. In 1991, 88% of surveyed high 
school seniors reported alcohol consumption, whereas 2010 surveys reported this 
percentage to be slightly above 70% (Johnston et al., 2011). While this is good news, 
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particularly if the trend continues, there is still a large proportion (70%) of high school 
seniors who are drinking and experimenting with alcohol and have already chosen to 
undertake the risk of EtOH exposure.  
Lifetime risk for alcohol use disorder declines with increasing age of first drink of 
alcohol (Prescott and Kendler, 1999), including subjects with family history positive for 
alcoholism, as examined in twin studies (Agrawal et al., 2009). Human adolescent binge 
drinking appears to be associated with alteration of white matter fiber tracts during 
adolescence, which has been related to cognitive performance deficits in adulthood 
(Jacobus et al., 2009, McQueeny et al., 2009). Also, fMRI data show that when 
anticipating reward, ventral striatal activation (an area analogous to the Acb examined in 
this study) is greater in adolescents compared to children and adults (Galvan et al., 
2006), suggesting a greater range of plasticity for reward-associated behavior may be 
present during adolescence. There is something about the adolescent neural system 
that makes it fundamentally different from periods before and after adolescence (Spear, 
2000). 
Use of the P rat as a subject in the present studies is meant to model possible 
perturbations of the systems seen in human adolescents that are identified as family 
history positive for alcoholism, particularly since about 50% of the variance in alcohol 
drinking behavior is accounted for by heredity (Bell et al., 2005, 2006, McKinzie et al., 
2005). Peri-adolescent EtOH consumption enhances EtOH intake in adulthood in both 
free-choice and operant settings (McKinzie et al., 1998b., Rodd-Henricks et al., 2002a, 
b, Bell et al., 2005). The present findings indicate that free-choice peri-adolescent EtOH 
consumption has long -lasting effects on EtOH reward pathways in adult P rats that are 
genetically predisposed to abuse EtOH. These effects increase the reward sensitivity of 
 
53 
 
lower concentrations of EtOH in the brain, as measured by a shift to the left of the dose- 
response curve for EtOH self-administered into the pVTA.  
Adolescent EtOH exposure increases DA clearance in the Acb, suggesting a 
general increase in DA release has occurred (Sahr et al., 2004). Adolescent subjects 
exhibit higher basal DA levels, as well as levels of D1 and D2 receptors, than adult 
subjects, emphasizing that DA tone differs overall in adolescents (Pascual et al., 2009). 
EtOH during adolescence increases basal DA in the Acb during adolescence (Philpot 
and Kirstein, 1998) and adulthood (Badanich et al., 2007), and down-regulates the levels 
of DRD2 receptors in prefrontal cortex, striatum and Acb of adolescent animals, but not 
of adult rats (Pascual et al., 2009). This indicates that despite identical treatment in 
adults, the DA system can be uniquely altered in adolescence. Adolescent EtOH 
exposure causes faster DA increase induced by EtOH administration into the Acb during 
adolescence and affects the accumbal ratio of DA to DOPAC (Philpot and Kirstein, 2004, 
Sahr et al., 2004), yet decreases DA response to an EtOH challenge within this brain 
structure (Philpot et al., 2009). Thus, EtOH has both acute and long-lasting effects on 
the DA system terminating in the Acb, which may be causal or correlational to increased 
EtOH consumption in adulthood. 
DA activation in the AcbSh in response to drug administration has been 
suggested to strengthen drug reward associations, a large part of addictive behavior 
(Koob and Le Moal, 1997, Di Chiara, 1998, Koob, 2010). Removal of EtOH access 
decreases DA and 5-HT in the Acb of EtOH-dependent subjects, an effect that is 
reversed when EtOH access is restored (Weiss et al., 1996). Suppression of EtOH 
operant reinforcement by naltrexone occurs simultaneously with a suppressed DA 
response in the Acb (Gonzalez and Weiss, 1998). During operant access for EtOH (as 
well as during an anticipatory pre-access period) DA levels are elevated in the AcbSh 
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(Weiss et al., 1993, Melendez et al., 2002). The literature evidencing DA change during 
reward is well established, but there is only a very limited focus when including the 
variable of adolescent EtOH exposure. 
When it came to examining EtOH consumption during adolescence in the current 
study, it was observed that Intake volume of EtOH for each subject during the 30 day 
access period has reached its peak by the end of the second week. This lack in 
statistical significance between later time blocks suggests that some neurobehavioral 
change has occurred by, or occurs at, the 2 week peri-adolescent EtOH access, 45 day 
of age period. EtOH preference continued to increase throughout the exposure period, 
as evidenced by statistically significant differences between all blocks compared to each 
other. This corresponds to data reported previously in P rats (Bell et al., 2003, Bell et al., 
2006). It appears that water volume consumption decreases by the end of a similar 30-
day peri-adolescent EtOH exposure period, resulting in increased preference ratios. 
Bodyweight increases at a constant rate throughout the whole exposure period, 
indicating this is not due to an observable growth spurt. As seen in the Appendix, this 
increase in preference ratio is significantly correlated when subjects’ drinking volumes 
are plotted in comparison of blocks, suggesting that while EtOH preference is 
significantly continuing to change over the full 30 day period, early EtOH preference 
predicts later EtOH preference. Levels of EtOH consumption by adolescent male P rats 
in this study was comparable to that of previous work with 15% v/v EtOH (Bell et al., 
2006), in g/kg/day intake as well as EtOH percent preference observed throughout the 
30 day access period. In the Bell et al., 2006 study, peri-adolescent subjects reached 
average BAC's of 56 mg% at two hours into the daily dark cycle, yet ranged as high as 
~150 mg%. This average corresponds to a moderate amount of alcohol consumed in the 
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human condition, while the highest concentrations correspond to binge or greater levels 
of EtOH intake (Eckardt et al., 1998, Bell et al., 2006).  
As in previous ICSA studies (Rodd-Henricks et al., 2000, Rodd et al., 2004, 
2005a), P rats responded on the active lever to self-administer EtOH directly into the 
pVTA during ICSA sessions 1-4, and extinguished responding when only vehicle was 
available (sessions 5 and 6). Additionally, the operant responding was reinstated in 
session 7 when EtOH infusions were again available (see Figures 8 - 12). 
Experimentally naïve female P rats self-administer EtOH at concentrations that have 
varied by study (150 mg% EtOH, but not 100 mg%; Rodd-Henricks et al., 2000, 75 mg% 
and higher; Rodd et al., 2004, 2005a). In the current study, subjects were male instead 
of female and substantially larger as a result. These naïve male P rats failed to self-
administer either vehicle or the three lowest EtOH concentrations (50, 75, and 100 mg%) 
to the pVTA, and did not discriminate the active lever from the inactive lever. At 150 
mg% concentration, naïve rats self-infused EtOH at a statistically significant level, and 
approached significance for lever discrimination (possibly diminished due to high 
variability between subjects on both the inactive and active levers). Compared to 
extinction session 5, reinstatement responding on the active lever during session 7 was 
significantly different. 
P rats that had free-choice access to EtOH during peri-adolescence also failed to 
self-administer 50 mg% EtOH and discriminate the active from the inactive lever. At the 
75, 100, and 150 mg% concentrations, however, peri-adolescent EtOH-exposed 
subjects readily self-administered EtOH to the pVTA, responded more on the active than 
inactive lever during acquisition, extinguished responding on the active lever when only 
aCSF was given, and reinstated responding on the active lever when EtOH was 
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restored. Thus, free-choice peri-adolescent EtOH exposure increased the sensitivity of 
the pVTA to the rewarding effects of EtOH in adulthood.  
Future work may find differences at higher concentrations of EtOH, as a previous 
study found that P rats exposed to EtOH constantly or intermittently in adulthood self-
infused higher concentrations of EtOH (300 mg%) into the pVTA, while naïve subjects 
did not (Rodd et al., 2005b). This high concentration was not examined in the current 
study. 
In the second study, the observed basal extracellular DA of the AcbSh (Figure 
13; Naïve subjects 1.10 (±0.12) nM, EtOH-Exp subjects 1.09 (±0.11) nM) of P rats 
corresponded within ranges previously observed (Engleman et al., 2000; Melendez et 
al., 2002, Sahr et al., 2004, Ding et al., 2009, Franklin et al., 2009), indicating both probe 
recovery of DA and DA analysis by HPLC were comparable to previous studies. 
Furthermore, basal extracellular DA data compared between groups support a previous 
study which also failed to find differences in basal DA in the Acb of peri-adolescent 
EtOH-exposed P rats compared to -naïve subjects (Sahr et al., 2004).  
Figures 14 - 18 illustrate the results of the MicroMicro experiments that measured 
DA extracellular concentrations (efflux) within the AcbSh in response to EtOH (50 - 150 
mg%) administered into the pVTA. Naïve P rats failed to show an increase in DA in the 
AcbSh in response to microinjections of the three lower concentrations of EtOH (50, 75, 
and 100 mg%) into the pVTA. Subjects with free-choice access to EtOH during peri-
adolescence did not show an increase at the 50 mg% level, but did display increases in 
extracellular DA within the AcbSh in response to microinjections of 75 and 100 mg% 
EtOH. The results from both the EtOH-exposed and -naïve subjects spanned a range of 
concentrations that were previously found to be below and above the threshold level  
that supported ICSA into the pVTA. Both groups showed an increase in AcbSh DA 
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response at the 150 mg% level, just as both groups displayed self-administration of 150 
mg% EtOH. These results show that free-choice peri-adolescent EtOH consumption has 
changed the way the VTA responds to EtOH in adulthood. Thus, free-choice adolescent 
EtOH exposure enhances the release of DA downstream from the pVTA in the AcbSh, 
upon EtOH application to the pVTA. 
Rodent subjects with a family history that predisposes them for high EtOH 
consumption have been shown to have lower levels of basal DA in the Acb compared to 
non-family-history-positive subjects, possibly connected with reduced DA release 
(Murphy et al., 1982, 1987). Long-term EtOH drinking has been shown to increase basal 
DA activity in the Acb of adult P rats (Thielen et al., 2004), which has been hypothesized 
to be related to increased sensitivity to the reinforcing effect of EtOH in the pVTA 
following EtOH access (Rodd et al., 2005b). While Acb DA transient events (fluctuations 
in DA under a second in duration) of adolescent subjects exist at baseline rates similar 
to adults, transient events in response to social and nonsocial stimuli differ, suggesting 
variations in novelty processing that may relate to reward salience (Robinson et al., 
2011). Therefore, it appears that DA variations and responsiveness in the Acb is related 
to EtOH reward, reinforcement, and a predisposition for high EtOH intake. 
The present study found that pulsed microinjections of EtOH administered to the 
pVTA, in a pattern similar to a bout of ICSA administration, are connected to increased 
extracellular DA concentrations in the AcbSh. This indicates further that stimulation of 
DA cell bodies in the pVTA projecting to the AcbSh is associated with the rewarding 
properties of EtOH. The present results also indicate that following peri-adolescent 
exposure to EtOH, lower concentrations of EtOH are required to produce observable DA 
in peri-adolescent exposed subjects than -naïve subjects. This indicates that the 
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subjective rewarding properties of EtOH within the pVTA can be been significantly 
altered by peri-adolescent EtOH exposure as well. 
As observed in hippocampal cells following EtOH exposure in adolescence 
(Crews et al., 2007, McClain et al., 2011a, b), it is possible that EtOH administration is 
disrupting scaffolding of normal interconnections, or inducing pruning where pruning 
should not occur, in ways that affect the VTA-AcbSh neurocircuit. It is normal for neural 
connections and ratios of proteins and receptors to be changing at this time; 
neurogenesis in the hippocampus (He and Crews, 2007), as well as DA receptor binding 
in the cortex and striatum, have been shown to decline over time (Jucaite et al., 2010, 
Weickert et al., 2007), indicating that receptor density is higher in many brain regions of 
the adolescent relative to adults. For instance, DAR1 mRNA expression has been shown 
to peak in adolescence (Weickert et al., 2007). These basal differences may be involved 
in the vulnerability that the peri-adolescent time period presents; perturbations of 
systems already changing (neurogenesis, changes in receptor density and expression) 
may result in an altered mesolimbic DA system that is primed for increased EtOH reward 
in adulthood.  
 
Conclusions 
 
The mesolimbic DA system is a critical part of the neuro-circuit that is vulnerable 
during adolescence, and when perturbed, may promote future excessive EtOH drinking 
behavior. Overall, the results of this study indicate that the consumption of EtOH by P 
rats during peri-adolescence produces persistent neuroadaptations within this 
mesolimbic DA system. Specifically, following peri-adolescent free-choice EtOH-
exposure in P rats, an increase in the sensitivity and reinforcing properties of EtOH in 
the pVTA was observed, as well as an increase in the sensitivity and efficacy of EtOH to 
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stimulate activation of the mesolimbic DA system. The focus on the mesolimbic DA 
system in the present study adds to a vast literature on the importance of this system in 
modulating alcohol abuse and alcoholism. It is, however, important to note that the 
mesolimbic DA pathway is potentially only one of many neurobiological substrates 
involved in the effects of alcohol and the mediation of drinking behavior. 
 An important aspect of the present study is that the EtOH was self-administered 
via free-choice drinking, compared with many other studies that used experimenter-
administered EtOH via injections or other passive methods. Experimenter-administered 
EtOH is complicated by stress associated with the aversive effects of restraint and 
administration of EtOH amounts that are not necessarily reinforcing to the animal. An 
extensive literature indicates that developmental stressors can have multiple deleterious 
and long-lasting effects on the adult animal. The approach taken in this study is one of 
only a few studies that have used free-choice drinking as a method to administer EtOH 
to adolescent animals, and the results may be more comparable to human adolescent 
drinking than experimenter-administered approaches.  
The translational implications of the present study are clear that adolescent 
alcohol drinking may increase the susceptibility to life-long alcohol abuse and 
alcoholism, particularly for individuals who have a high hereditary propensity to 
excessive alcohol use. According to a number of physical and neurobiological markers, 
the PD 30 - 60 used in the present study is reasonable approximation of the human 
adolescent period. However, one caveat of the present study is that adolescent children 
are likely to drink in binges when alcohol is available, unlike the continuous free-choice 
drinking approach used in this study. On the other hand, binge drinking has repeatedly 
been observed in many studies to cause even more severe deleterious effects than 
continuous drinking on behavior and neurobiological dependent measures. Thus, future 
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studies that investigate binge-like exposure in P rats would likely yield similar or even 
more pronounced effects as observed in the current results. Additionally, it is possible 
that similar findings would occur with EtOH exposure during other developmental 
periods before or after this PD 30 - 60 adolescent window, as well as free-choice 
drinking periods that span less than 30 days.  
Future directions should explore other EtOH exposure parameters with regard to 
this adolescent EtOH exposure model to evaluate differences observed during EtOH 
drinking and/or post-EtOH binge-like access in adolescence. For example, studies might 
include examination of other neurotransmitters or brain areas, use of RT-PCR to 
determine changes in G-proteins or other intracellular signaling pathways, or receptor 
binding and receptor subunit analyses. Moreover, an important future direction is that 
these findings present an opportunity to develop pharmacological interventions that may 
prevent and/or ameliorate these peri-adolescent ETOH-drinking induced 
neuroadaptations. 
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Figure A1. Blocks of EtOH Access. Illustration of breakdown of peri-adolescent EtOH 
access days into six blocks of five days each for comparison of means.  
 
 
 
 
 
Figure A2. Block 1 Compared to Block 2. These blocks are significantly different for 
Intake (p < 0.001) and Preference (p < 0.001). Proportion of explained variance (r2 ) for 
Intake is 0.41 (F1,174 = 121.23, p < 0.001). The r
2 for Preference is 0.38 (F1,174 = 105.95, p 
< 0.001).  
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Figure A3. Block 1 Compared to Block 3. These blocks are significantly different for 
Intake (p < 0.001) and Preference (p < 0.001). Proportion of explained variance (r2 ) for 
Intake is 0.18 (F1,174 = 38.38, p < 0.001), while the r
2 for Preference is 0.26 (F1,174 = 
62.94, p < 0.001). 
 
Figure A4. Block 1 Compared to Block 4. These blocks are significantly different for 
Intake (p < 0.001) and Preference (p < 0.001). Proportion of explained variance (r2 ) for 
Intake is 0.09 (F1,174 = 17.5, p < 0.001), while the r
2 for Preference is 0.14 (F1,174 = 28.59, 
p < 0.001).  
 
 
Figure A5. Block 1 Compared to Block 5. These blocks are significantly different for 
Intake (p < 0.001) and Preference (p < 0.001). Proportion of explained variance (r2 ) for 
Intake is 0.27 (F1,174 = 11.81, p = 0.001), while the r
2 for Preference is 0.08 (F1,174 = 
15.42, p < 0.001).  
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Figure A6. Block 1 Compared to Block 6. These blocks are significantly different for 
Intake (p < 0.001) and Preference (p < 0.001). Proportion of explained variance (r2 ) for 
Intake is 0.01 (F1,174 = 2.52, p = 0.114), while the r
2 for Preference is 0.04 (F1,174 = 8.30, p 
= 0.004).  
 
 
Figure A7. Block 2 Compared to Block 3. These blocks are significantly different for 
Intake (p < 0.001) and Preference (p < 0.001). Proportion of explained variance (r2 ) for 
Intake is 0.41 (F1,174 = 124.85, p < 0.001), while the r
2 for Preference is 0.67 (F1,174 = 
349.96, p < 0.001). 
 
 
Figure A8. Block 2 Compared to Block 4. These blocks are significantly different for 
Intake (p < 0.001) and Preference (p < 0.001). Proportion of explained variance (r2 ) for 
Intake is 0.21 (F1,174 = 47.88, p < 0.001), while the r
2 for Preference is 0.36 (F1,174 = 
99.33, p < 0.001).  
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Figure A9. Block 2 Compared to Block 5. These blocks are significantly different for 
Intake (p < 0.001) and Preference (p < 0.001). Proportion of explained variance (r2 ) for 
Intake is 0.11 (F1,174 = 21.23, p < 0.001), while the r
2 for Preference is 0.28 (F1,174 = 68.6, 
p < 0.001).  
 
 
 
Figure A10. Block 2 Compared to Block 6. These blocks are significantly different for 
Intake (p < 0.001) and Preference (p < 0.001). Proportion of explained variance (r2 ) for 
Intake is 0.06 (F1,174 = 12.00, p = 0.001), while the r
2 for Preference is 0.21 (F1,174 = 
46.87, p < 0.001).  
 
Figure A11. Block 3 Compared to Block 4. These blocks are significantly different for 
Intake (p = 0.03) and Preference (p < 0.001). Proportion of explained variance (r2 ) for 
Intake is 0.37 (F1,174 = 102.59, p < 0.001), while the r
2 for Preference is 0.57 (F1,174 = 
235.62, p < 0.001).  
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Figure A12. Block 3 Compared to Block 5. These blocks are not significantly different for 
Intake (p = 0.09) but are significantly different for Preference (p < 0.001). Proportion of 
explained variance (r2 ) for Intake is 0.23 (F1,174 = 51.71, p < 0.001), while the r
2 for 
Preference is 0.41(F1,174 = 123.18, p < 0.001).  
 
Figure A13. Block 3 Compared to Block 6. These blocks are not significantly different for 
Intake (p = 0.20) but are significantly different for Preference (p < 0.001). Proportion of 
explained variance (r2 ) for Intake is 0.26 (F1,174 = 26.44, p < 0.001), while the r
2 for 
Preference is 0.13 (F1,174 = 63.23, p < 0.001). 
 
Figure A14. Block 4 Compared to Block 5. These blocks are not significantly different for 
Intake (p = 0.19) but are significantly different for Preference (p < 0.001). Proportion of 
explained variance (r2 ) for Intake is 0.70 (F1,174 = 417.32, p < 0.001), while the r
2 for 
Preference is 0.71 (F1,174 = 430.55, p < 0.001).  
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Figure A15. Block 4 Compared to Block 6. These blocks are not significantly different for 
Intake (p = 0.53) but are significantly different for Preference (p < 0.001). Proportion of 
explained variance (r2 ) for Intake is 0.28 (F1,174 = 66.73, p < 0.001), while the r
2 for 
Preference is 0.42 (F1,174 = 125.88, p < 0.001).  
 
Figure A16. Block 5 Compared to Block 6. Blocks 5 and 6 are not significantly different 
for Intake (p = 0.07) but are significantly different for Preference (p < 0.001). Proportion 
of explained variance (r2 ) for Intake is 0.47 (F1,174 = 153.80, p < 0.001), while the r
2 for 
Preference is 0.63 (F1,174 = 299.56, p < 0.001).  
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